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Abstract 
In this study, different aspects of vesicular transport in the early secretory 
pathway have been investigated.  
 
Although an earlier study showed an effect upon the down regulation of β-COP 
in the transport of the SH4 domain containing HASPB and Yes (Ritzerfeld et 
al., 2011), there was no study revealing the role of coatomer subunits in plasma 
membrane localization of unconventionally secreted proteins. This work 
investigates the role of γ2-COP in the transport of the unconventionally 
secreted proteins HASPB and Yes. Pronounced retention of HASPB at the 
perinuclear region was observed after down regulation of the coatomer 
subunits α, β, δ, and ζ suggesting that the coatomer subunits and therefore 
most likely COPI vesicles are involved in the transport of HASPB. However 
individual knockdowns of γ1- and γ2-COP subunits did not affect the transport 
of the reporter proteins, indicating there is no specific role of coatomer isoforms 
per se.  
 
In the second part, the impact of novel Brefeldin A (BFA) analogs on the Golgi 
morphology was investigated. Treatments of mammalian cells with various 
analogues revealed that number of derivatives had no impact on the Golgi 
morphology in given times in addition to some derivatives causing reversible 
Golgi disruption as Brefeldin A. The variation of the effect can be of use in 
various fields for creating new therapeutics.  
 
Another part of this work focusing on the oligomerization of the p24 protein and 
a non-SM18 binding p24 variant (L17F) were studied by cross-linking the 
proteins in vivo using a chemical cross-linking agent. This shows a significant 
reduction in the oligomeric form of the non-SM18 binding p24 variant compared 
to the monomeric form.  
 
The final part of this thesis presents the findings on the kinetics of p24 family 
members using Fluorescent Loss in Photobleaching (FLIP). Experiments 
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resulted in no significant differences between transport rates of p23 and p24 
from the Golgi to the endoplasmic reticulum. 
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Zusammenfassung 
Im Rahmen dieser Arbeit wurden verschiedene Aspekte des vesikulären 
Transports im frühen sekretorischen Weg untersucht. 
 
Obwohl frühere Arbeiten die Auswirkung der Herunterregulierung von β-COP 
auf den intrazellulären Transport von SH4-Fusionsproteinen (Ritzerfeld et al., 
2011) zeigen, gibt es keine Untersuchungen bezüglich der Rolle von Coatomer 
Untereinheiten bei der Plasmamembranlokalisierung von unkonventionell 
sezernierten Proteinen. In dieser Arbeit wurde die Rolle von γ2-COP beim 
Transport der unkonventionell sezernierten Proteine HASPB und Yes 
untersucht. In Folge der Herunterregulierung der Coatomer Untereinheiten α, 
β, δ und ζ konnte eine deutliche Retention von HASPB in der perinukleären 
Region festgestellt werden. Das deutet darauf hin, dass diese Coatamer 
Untereinheiten und somit COPI-Vesikel am Transport von HASPB beteiligt 
sind. Allerdings hatte der einzelne Knock-down von γ1- und γ2-COP 
Untereinheiten keinen Einfluss auf den Transport der Reporterproteine. Dies 
weist darauf hin, dass die Coatomer Isoformen an sich keine spezifische 
Funktion bei dieser Art von Transport haben. 
 
Zudem wurden neuartige Brefeldin A (BFA)-Analoga hinsichtlich ihres 
Einflusses auf die Morphologie des Golgi-Apparates untersucht. Es konnte 
gezeigt werden, dass einige Derivate keinerlei Wirkung auf die Golgi-
Morphologie haben, wogegen andere wie BFA einen reversiblen Zerfall des 
Golgi-Apparates verursachen. Die Bandbreite der unterschiedlichen Effekte 
kann in verschiedenen Einsatzbereichen genutzt werden, um neue 
Therapeutika herzustellen. 
 
Des Weiteren wurde in vivo die Oligomerisierung des p24-Proteins und einer 
p24-Variante, die die Sphingomyelinspezies (SM18) nicht mehr bindet (L17F), 
mittels chemischer Quervernetzung untersucht. Diese Studien zeigten eine 
erhebliche Abnahme der oligomeren Form der p24-Variante im Vergleich zur 
monomeren Form.  
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Im letzten Teil dieser Arbeit werden die Ergebnisse bezüglich der Kinetik der 
p24-Familienmitglieder unter Verwendung von Fluorescent Loss in 
Photobleaching (FLIP) vorgestellt. Dabei zeigten sich keine signifikanten 
Unterschiede zwischen p23 und p24 bezüglich ihrer Transportraten vom Golgi 
zum Endoplasmatischen Retikulum.  
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1. Introduction 
 
A hallmark of eukaryotic cells are their characteristic membrane structures in 
the cytoplasm. These membrane enclosed organelles are necessary for 
specific metabolic activities that are vital for the cell. The specific compositions 
of these organelles are conserved although there is a continuous molecular 
exchange between the organelles within a cell. Protein and lipid homeostasis 
in eukaryotic cells depends on many cellular processes, including highly 
regulated transport between the membrane bound compartments carried out 
by conventional and unconventional secretion. The majority of newly 
synthesized cargo follows the secretory pathway in transport vesicles, starting 
at the Endoplasmic Reticulum (ER), followed by the Golgi apparatus and from 
there to its final destination in the cell. However, quite a number of proteins are 
secreted without entering this pathway or bypassing organelles on the way, 
which has been termed unconventional secretion (Rabouille et al., 2012). 
 
1.1. Conventional secretory pathway 
 
The classical secretory pathway in the cell begins at Endoplasmic Reticulum 
and the cargo is directed from ER to plasma membrane, endosomal-lysosomal 
system or other organelles. Throughout the secretory pathway in eukaryotic 
cells, a variety of coated vesicles are responsible for the delivery of cargo. They 
are also involved in sorting mechanisms at the membrane, which is important 
to maintain the composition of the organelles (Bonifacino and Glick, 2004; 
Cottom and Ungar, 2012). In the early part of the secretory pathway, between 
ER and Golgi, vesicular transport occurs bidirectionally; Coat Protein Complex 
II coated (COPII) vesicles are responsible for anterograde transport from ER to 
Golgi and Coat Protein Complex I coated (COPI) vesicles mediate the 
retrograde transport from Golgi to ER as well as the bidirectional transport 
within the Golgi apparatus (Nakano et al., 2009; Sato, 2004).  
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1.1.1. COPII coated vesicles  
 
Biogenesis of the COPII vesicles begins with the activation of a small GTPase: 
Sar1. Sar1 acts as a molecular switch between inactive GDP-bound state to 
active GTP-bound state and this switch is controlled by Guanine Exchange 
Factors (GEF) (Adolf et al., 2013). Active Sar1 binds to a Sec23/Sec24 dimer, 
which is a heterodimeric subcomplex of the COPII coat (Szul and Sztul, 2011). 
Subsequently, the Sec13/Sec31 heterotetrameric complex is recruited to the 
Sec23/24 part of the coat (Farhan and Rabouille, 2011; Lee et al., 2004), which 
induces coat polymerization that leads to the formation of a vesicle (Hicke et 
al., 1992; Matsuoka et al., 1998; Salama et al., 1993). In addition to the minimal 
machinery, COPII vesicles contain newly synthesized cargo to be transported 
to the Golgi for further processing and maturation (Hirschberg and Lippincott-
Schwartz, 1999). Sorting of the cargo occurs at the ER exit sites (ERES), where 
the sorted cargo, further targeting molecules (v-SNARE (vesicle-soluble NSF 
(N-ethylmaleimide-sensitive factor) attachment protein receptor)) (Campbell 
and Schekman, 1997), and receptors (e.g. p24 proteins) are concentrated and 
later form COPII vesicles (Zanetti et al., 2012).  
 
1.1.2. COPI coated vesicles 
 
The small GTPase Arf1 (ADP-ribosylation factor 1) initiates biogenesis of the 
COPI vesicles. Arf1-GDP is recruited in its inactive form to the Golgi membrane 
from the cytosol by the C-terminal tail of the p24 family members (Gommel et 
al., 2001). Arf1-GDP is then activated by the nucleotide exchange factor GBF1 
(which was erroneously named Golgi-specific Brefeldin A resistant guanine 
nucleotide exchange factor 1) catalyzing exchange of GDP to GTP in Arf1. 
Upon GTP loading, Arf1 undergoes a conformational change and increases 
membrane binding by inserting its amphipathic helix into the membrane 
(Antonny et al., 1997; Niu et al., 2005). Arf1, together with p24 family members, 
recruits a soluble cytosolic heptameric complex termed coatomer to the Golgi 
membrane. Binding to p24 family members causes a conformational change 
and initiates the polymerization of coatomer (Reinhard et al., 1999). 
Subsequently, the polymerization of the coat protein causes membrane 
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deformation and COPI vesicles bud off from the membrane (Bethune et al., 
2006). When COPI vesicles reach their target membrane, a first attachment 
occurs via tethering factors, followed by association of SNAREs between two 
membranes, which leads to fusion and the release of their content (Cottom and 
Ungar, 2012). Several reports indicate that the COPI system is involved in the 
homeostasis of lipids (Beller et al., 2008; Soni et al., 2009) as well as protein 
transport in the cell (Lippincott-Schwartz and Liu, 2006; Rothman and Wieland, 
1996; Serafini et al., 1991b). 
 
1.1.2.1. ADP-ribosylation factor 1(Arf1) 
 
Arf1 is a small guanosine triphosphatase (GTPase) that mainly regulates 
vesicular traffic (Casanova, 2007; D'Souza-Schorey, 2006). Nucleotide 
exchange of Arf-GDP to Arf-GTP via GBF1 (Golgi-specific Brefeldin A resistant 
guanine nucleotide exchange factor 1) triggers a conformational change in Arf1, 
which then inserts its N-terminal myristoylated helix into the membrane 
(Antonny et al., 1997). This shallow insertion helps to create positive curvature 
at the membrane that eventually allows formation of a bud (Beck et al., 2008).  
 
Nucleotide exchange factor GBF1 (in spite of its name) is known to be Brefeldin 
A sensitive. Brefeldin A is a unique fungal metabolite and has an unusual 
reversible effect on Golgi morphology. It causes a block of protein transport 
between ER and Golgi in eukaryotic cells (Fujiwara et al., 1988). Brefeldin A 
binds to a Arf-GDP-Sec7 domain complex (the first intermediate in the 
nucleotide exchange process) and prevents the exchange of GTP for GDP, 
thereby blocking the association of Arf with Golgi membranes and inhibition of 
COPI mediated transport (Claude et al., 1999; Donaldson et al., 1992; Helms 
and Rothman, 1992a; Peyroche et al., 1999). Additionally, Brefeldin A causes 
apoptosis and reduces proliferation of cancer cells, and is a topic of intensive 
research (Seehafer et al., 2013; Shao et al., 1996). Furthermore, BFA is known 
to be an inhibitor of enterovirus RNA replication in infected cells and to cause 
an assembly defect on Herpes Simplex Virus type1 (Cuconati et al., 1998; 
Dasgupta and Wilson, 2001).  
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As BFA is an important tool in different fields of research, analogues were 
synthesized in the anticipation of improved in vivo stability and solubility while 
rendering the compound less toxic for the cells. The cytostatic activity however 
should be maintained when compared to the original BFA (Förster et al., 2011b; 
Seehafer et al., 2013). Two separate batches of newly synthesized Brefeldin A 
analogues were tested for their biological properties in mammalian cells for 
their effect on Golgi morphology in this thesis (see Chapter II).  
 
Recruitment of coatomer and stabilizing the complex at the membrane requires 
several interactions between Arf1, coat proteins and membrane proteins. Arf1 
interaction with different coatomer subunits has been shown in vitro by site 
specific photo-crosslinking experiments to include β- and γ-COP as well as β’- 
and δ-COP (Sun et al., 2007; Zhao et al., 1997; Zhao et al., 1999). Furthermore, 
an interaction with ε-COP was found in two hybrid experiments (Eugster et al., 
2000; Sun et al., 2007). In vitro crosslinking and Foerster resonance energy 
transfer (FRET) experiments in live cells reveals an interaction between C-
terminal tails of the Arf1-GDP with dimeric members of the p24 family (Gommel 
et al., 2001; Majoul et al., 2001). These interactions stabilize coatomer at the 
membrane.  
 
1.1.2.2. p24 family members 
 
p24 proteins are a family of highly conserved type I transmembrane proteins 
with a molecular weight range of 24 kDa, and are important players in the early 
secretory pathway. The topological characteristics of these proteins are large 
N-terminal luminal domains, a single transmembrane segment and a 
cytoplasmically exposed short (12-20 amino acids) C-terminal tail. The latter 
allows the binding of the coat proteins I and II (Dominguez et al., 1998; Fiedler 
et al., 1996; Sohn et al., 1996).   
 
The p24 family members were categorized and named differently, which also 
differs between species. As a result, various nomenclatures exist. According to 
phylogenetic clustering, they can be divided into four subfamilies, known as 
p24α, p24β, p24γ and p24δ, most of which exist in eukaryotic species 
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(Dominguez et al., 1998; Strating et al., 2009). The number of representatives 
of each subfamily differs across the species and typically 8-11 total members 
were found per genome (Dancourt and Barlowe, 2010; Strating et al., 2009). In 
this thesis, mainly two important members of this family will be examined: p23 
and p24, which belong to the p24δ and p24β subfamilies, respectively.  
 
Most p24 proteins form heterooligomers. This was shown by immune-
precipitation: The p23 and p24 proteins form a complex and there is also 
efficient in vivo crosslinking (Fiedler and Rothman, 1997; Gommel et al., 1999; 
Jenne et al., 2002). Further studies show that there is a highly dynamic and 
complex interaction between the p24 family members except two of the 
subfamily members, p26 and tp24 (Jenne et al., 2002). In addition to 
monomeric and dimeric forms, p24 family members can form tetramers via their 
cytoplasmic domains and higher oligomeric forms were observed upon in vivo 
crosslinking via transmembrane domains (TMD) (Contreras et al., 2012; Jenne 
et al., 2002; Wiedler et al., 2000). Oligomerization of the family members is 
important for their correct localization and stability (Jenne et al., 2002). p24 
dimers interact with γ trunk and appendage domains, which stabilizes coatomer 
on the Golgi membrane (Bethune et al., 2006; Harter and Wieland, 1998; Popoff 
et al., 2011a). Recently, in addition to the oligomerization of the p24 family 
members, an interaction of a specific lipid species, sphingomyelin (SM 18:0), 
and p24 was discovered. FRET experiments with fluorescent lipids revealed 
that lipid-protein interaction increases oligomerization of p24 and modulates the 
efficiency of COPI-vesicle mediated retrograde trafficking (Contreras et al., 
2012). The oligomerization of p24 and a non-SM18 binding variant of the 
protein is investigated by in vivo crosslinking in Chapter III.  
 
p24 family members cycle between the membranes of the early secretory 
pathway. Several functions, including COPI vesicle biogenesis, have been 
proposed (Gommel et al., 1999; Jenne et al., 2002): One proposed function is 
that of a cargo receptor. Deletions of the analog of p24 (Emp24p) in yeast have 
revealed a transport delay of the glycosylphosphatidylinositol (GPI)-anchored 
protein Gas1p (Schimmoller et al., 1995). A knockdown of p23 resulted in a 
delay of the plasma membrane expression of GPI-anchor proteins in general 
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and slowed down the maturation of a specific GPI-anchor protein:  DAF (decay-
accelerating factor). Other non-GPI-anchor proteins, however, were hardly 
affected. These data suggest that the transport of GPI-anchored proteins is 
regulated by p23 and p24 (Takida et al., 2008). p23 and p24 also work in the 
ER export of GPI-anchored proteins as cargo receptors by facilitating the ER 
export of these proteins depending on the interaction of certain Sec24 isoforms 
with p23-p24 complexes (Bonnon et al., 2010). p23 was, furthermore, shown to 
have a receptor function for coatomer at the Golgi membrane (Sohn et al., 
1996) and p24 proteins were found as cargo receptors for Wnt proteins and 
required for their exit from ER (Buechling et al., 2011).  
 
Members of the p24 family were proposed to contribute to the structural 
maintenance of the Golgi (Denzel et al., 2000) as well as to the formation of ER 
exit sites (Lavoie et al., 1999). Additionally, mutations of p24 proteins can 
influence structural organization of the ER and the Golgi apparatus (Aguilera-
Romero et al., 2008; Lavieu et al., 2010; Mitrovic et al., 2008). Inactivation of 
one allele of p23 in mice causes structural changes in the Golgi structure 
(Denzel et al., 2000) and p23 was proposed to play a role to form and maintain 
the membrane structure of the cis-Golgi Network (CGN) (Rojo et al., 2000). 
However, in these reports, p23 was exogenously overexpressed, and it has 
been shown that overexpression of the p24 family members causes their 
mislocalization and accumulation at the ER. Therefore overexpression of p24 
family members is prone to artifacts due to unphysiological localizations (Blum 
et al., 1999; Dominguez et al., 1998; Fullekrug et al., 1999; Rojo et al., 2000).  
 
Genetic and biochemical experiments performed with mutant mouse strains 
revealed that p23 and p24 are required in the embryonic development in mouse 
embryos and placenta (Denzel et al., 2000; Jerome-Majewska et al., 2010). In 
yeast, deletion of the p24 family members shows only a reduction of the 
transport rate of some cargo and does not affect cell viability or result in a 
severe protein transport phenotype (Denzel et al., 2000; Marzioch et al., 1999). 
However, more recently evidence for a direct role of the yeast p24 complex was 
reported in vesicle budding under coat-limiting conditions (Aguilera-Romero et 
al., 2008).  
17 
 
 
Various family members localize within the early secretory pathway (Emery et 
al., 2000). At a steady state, p24 family members are found abundantly in the 
CGN (cis-Golgi Network)(Dominguez et al., 1998). Biochemical assays and 
subcellular fractionations revealed that p24 family members are present in 
different oligomeric states in different organelles. Furthermore, temperature 
blocks and quantitative western blot analysis in HeLa cells revealed that p24 
and p25 localize equally to all membranes.  p23 and p27 however, build up 
opposing gradients, with p23 being more abundant in the ER and ERGIC and 
less abundant in the Golgi, and p27 showing the opposite gradient (Jenne et 
al., 2002). While all the other p24 family members occur as dimeric and even 
tetrameric forms, p26 is present in the early secretory membranes as a 
monomer, and does not interact with other members of the family (Jenne et al., 
2002).  
 
p23 and p24 carry different localization signals in their cytoplasmic tail 
(Dominguez et al., 1998). The tail of many p24 family members contains 
phenylalanine residues, whereas only a subset of family members contains a 
double lysine motif close to the C-terminus (Fiedler et al., 1996; Nickel et al., 
1997; Sohn et al., 1996), similar to the cytoplasmic tails of ER resident proteins 
that contain KKXX retrieval motifs (Nickel et al., 1997). Combination of dilysine 
and double phenylalanine motifs (FFXX(K/R)(K/R)Xn (n ≥ 2)) in the cytoplasmic 
tail of the p24 family members allow the binding to COPI via γ-COP and COPII 
via Sec23 (Bethune et al., 2006; Dominguez et al., 1998; Nickel et al., 1997; 
Popoff et al., 2011a). In vivo mutational analyses confirm the role of both motifs; 
mutations in one protein can also effect the location of other non-mutated 
members of the p24 family, presumable as a consequence of their oligomeric 
properties (Dominguez et al., 1998).  
 
As different signals keep p24 family members in the early secretory pathway, 
this could also be the reason for their different kinetics of cycling (Popoff et al., 
2011). Immunofluorescence labeling revealed two distinct groups of p24 family 
members, distinguished by different Golgi to ER travel rates (Eva Emig, PhD 
thesis). In the light of this preliminary data, we investigated the kinetics of the 
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p24 family members in more detail. The possibility to categorize the p24 family 
into two kinetically different subfamilies could help to understand the different 
functions and/or different trafficking routes within the early secretory pathway 
of the family members in a more general way. Fluorescent Loss in 
Photobleaching (FLIP) was used to investigate the export rate of the p24 family 
members from ER to Golgi (see Chapter IV). Another method to selectively 
follow up protein trajectories was opened up by the recent development of 
photoactivatable fluorescent proteins (PAFPs). The PAFP Dronpa is most 
suitable for our purposes as it is monomeric, brighter than GFP and can be 
switched on and off by different wavelengths of light more than 100 times (Day 
and Davidson, 2009). Dronpa tagged p24 protein family members can be 
activated at the location of interest and their path can be followed up throughout 
the cell (see Chapter IV).  
 
1.1.2.3. Coatomer 
 
Coatomer is a cytosolic protein complex (550kD), which consist of seven 
subunits: α-COP (138 kDa), β-COP (107 kDa), β’-COP (102 kDa), γ-COP (97 
kDa), δ-COP (57 kDa), ε-COP (34 kDa) and ζ-COP (20 kDa) (Serafini et al., 
1991a; Stenbeck et al., 1993; Waters et al., 1991). In an Arf1-GTP dependent 
manner, the heptameric coat complex is recruited en bloc from the cytosol to 
the membrane (Hara-Kuge et al., 1994). 
 
The two coatomer subunits γ-COP and ζ-COP exist in two homologs termed 
γ1-, γ2-, and ζ1-, ζ2-COP (Futatsumori et al., 2000). Different homologs of the 
subunits result in four different isoforms of coatomer. These isoforms are 
named according to their content of the variable subunits: γ1ζ1, γ2ζ1, γ1ζ2, and 
γ2ζ2. In mammalian cells, different amounts of these subunits were observed: 
53% of γ1ζ1, 26% of γ2ζ1, 16% of γ1ζ2 and 5% of γ2ζ2 isoform (Moelleken et 
al., 2007). Furthermore, the coatomer isoforms localize at significantly different 
ratios across the Golgi apparatus of mammalian cells (Moelleken et al., 2007). 
While γ1ζ1 and γ1ζ2 isoforms were located at the cis part of the Golgi, γ2ζ1 
isoform was located mainly to the trans-Golgi (Moelleken et al., 2007). Different 
localization and ratios of the coatomer subunits suggests different sites of 
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budding for each of them with possibly carrying different cargo (Moelleken et 
al., 2007; Popoff et al., 2011b) 
 
1.2. Unconventional secretion 
 
Unconventional protein secretion summarizes different types of pathways, 
which are independent of the conventional secretory pathway (ER-Golgi). 
Unconventionally secreted proteins lack signal peptides, and either bypass an 
organelle of the conventional pathway or do not enter at all (Nickel, 2010; 
Rabouille et al., 2012). These proteins are not affected by inhibitors of vesicular 
transport like e. g. Brefeldin A (Nickel, 2010). An increasing number of proteins 
are found to be secreted unconventionally, e.g. SH4 domain containing 
proteins. Parasitic surface protein HASPB (hydrophilic acylated surface protein 
B) and Src kinase Yes both are examples of N-terminal SH4 domain containing 
proteins (Tournaviti et al., 2007). The SH4 domain is required and sufficient for 
proper transport and attachment of HASPB and Yes to the plasma membrane 
(Ritzerfeld et al., 2011).  
 
Data based on a genome-wide screen suggests that down regulation of certain 
coatomer subunits disturbs secretion of some SH4 domain containing reporter 
proteins (SH4-proteins). Furthermore, after knockdown of γ2-COP (but not γ1-
COP) the SH4 domain containing protein HASPB accumulates in the 
perinuclear region, while Yes is correctly transported to the plasma membrane 
(Walter Nickel, unpublished). In the light of this information, we investigated the 
possible function of the γ2-COP in the transport of the SH4 proteins. To this 
end, stable cell lines expressing the SH4-proteins were used to perform 
coatomer subunit knockdowns for investigating intracellular localization of the 
reporter proteins under the knockdown conditions (Ritzerfeld et al., 2011)(see 
Chapter I). 
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2. Materials and Methods 
 
2.1. Materials 
 
2.1.1. Chemicals and Consumables 
 
Instead of the once which are mentioned specifically, commonly used 
chemicals and consumables were purchased from the listed companies below. 
Merck (Darmstadt), Sigma (Deisenhofen), Roth (Karlsruhe), Fluka 
(Taufkirchen), Qiagen (Hilden), BioRad (Munich), Boehringer (Mannheim) and 
Life Technologies (Darmstadt). 
  
2.1.2. Enzymes 
 
EcoRI New England Biolabs (Frankfurt am Main, Germany) 
BamHI New England Biolabs (Frankfurt am Main, Germany) 
BamHI Hi-Fi New England Biolabs (Frankfurt am Main, Germany) 
NotI New England Biolabs (Frankfurt am Main, Germany) 
XbaI New England Biolabs (Frankfurt am Main, Germany) 
XhoI New England Biolabs (Frankfurt am Main, Germany) 
SbfI New England Biolabs (Frankfurt am Main, Germany) 
SacI New England Biolabs (Frankfurt am Main, Germany) 
SacII New England Biolabs (Frankfurt am Main, Germany) 
FspI New England Biolabs (Frankfurt am Main, Germany) 
PvuI New England Biolabs (Frankfurt am Main, Germany) 
DpnI New England Biolabs (Frankfurt am Main, Germany) 
Taq Polymerase Bio-cat (Heidelberg, Germany) 
Pfu Turbo Polymerase Agilent Technologies(Germany) 
Taq Polymerase Axon Labortechnik (Germany) 
T4 DNA Ligase Thermo Scientific (Germany) 
 
2.1.3. Antibodies 
 
2.1.3.1. Primary Antibodies 
 
Epitope Name Species 
Dilution 
(WB) 
Dilution (IF) 
p23 Henriette Rabbit 1:10 000 - 
p24 Elfriede Rabbit 1:10 000 - 
TMED2 TMED2 Mouse 1:1000 - 
α-COP 1PSL Rabbit 1:1000 - 
β-COP B1, 2 Rabbit 1:2000 - 
δ-COP R877 Rabbit 1:1000 - 
γ1-COP g1.2 Guinea pig 1:10 000 - 
γ2-COP g2.2 Guinea pig 1:10 000 - 
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Epitope Name Species 
Dilution 
(WB) 
Dilution (IF) 
γ1/γ2-COP γ-r Rabbit 1:10 000 - 
ζ1-COP R468.1 Rabbit 1:5000 - 
ζ2-COP R442 Rabbit 1:5000 - 
GAPDH GAPDH Mouse 1:5000 - 
GFP Abcam Mouse 1:1000 - 
GFP      Abcam Goat used for IP used for IP 
GFP Abcam Rabbit 1:1000 - 
Tubulin YL1/2 Rat 1:500 - 
MannosidaseII Rab1 Rabbit 1:1000 - 
MannosidaseII Rab2 Rabbit - 1:100-1:500 
GM130 GM130 Mouse - 1:1000 
Calnexin Stressgen Rabbit - 1:100 
Lamp2 Lamp2 Rat - 1:100 
EEA1 EEA1 Goat - 1:100 
ERGIC53 ERGIC53 Mouse - 1:100 
KDEL KDEL Mouse - 1:100 
TABLE 1: List of primary antibodies used 
 
2.1.3.2. Secondary Antibodies 
 
2.1.3.2.1. Antibodies for Immunofluorescence Labeling 
 
Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) 
Alexa Fluor® 488 Goat Anti-Mouse IgG (H+L) 
Alexa Fluor® 546 Goat Anti-Rabbit IgG (H+L) 
Alexa Fluor® 546 Goat Anti-Mouse IgG (H+L) 
 
2.1.3.2.2. Antibodies for Li-COR Odyssey 
 
Alexa Fluor 680 goat anti-rabbit IgG 
Alexa Fluor 680 goat anti-mouse IgG 
 
Secondary antibodies were manufactured by Life Technologies (Darmstadt, 
Germany). 
 
2.1.4. Bacterial Strains 
 
The E. coli strains DH5α and DH10ß; used for subcloning and plasmid 
propagation were purchased (Invitrogen, Carlsbad, USA).  
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2.1.5. Protease Inhibitors 
 
To inhibit the protease activity in the cell lysis protocols Protease-inhibitor-
cocktail tablets (Complete, EDTA-free) manufactured by Roche (Mannheim, 
Germany) were used. 
 
2.1.6. Protein and DNA Standards  
 
Precision Plus Protein™ All Blue Standards Bio-Rad Laboratories GmbH 
(Munich, Germany) 
 
100 bp DNA Ladder New England Biolabs 
(Frankfurt am Main, Germany)  
 
2.1.7. Chemical Crosslinkers 
 
DMP (Dimethyl pimelimidate•2 HCl)          Thermo Scientific (Illinois, USA) 
DSG (Disuccinimidyl glutarate)           Thermo Scientific (Illinois, USA) 
 
2.1.8. Transfection Reagents  
 
Oligofectamine™ Transfection Reagent Life technologies (Darmstadt, 
Germany) 
Lipofectamine™ 2000 Transfection Reagent Life technologies (Darmstadt, 
Germany) 
FuGENE® HD Transfection Reagent   Promega (Wisconsin, USA) 
 
2.1.9. MRA Treatment 
 
Mycoplasma Removal Agent                         MP Biomedicals (California, USA) 
 
2.1.10. Antibiotics  
 
Doxycycline                                                    BD Biosciences (California, USA) 
Ampicilin GERBU Biotechnik GmbH   
(Heidelberg, Germany)  
Kanamycin GERBU Biotechnik GmbH   
(Heidelberg, Germany) 
 
2.1.11. Growth Media  
 
LB (Luria Broth) Media was used to grow the E.coli strains. 
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2.1.12. Cell Lines 
 
Name of the Cell 
Line 
Cell Line Origin Medium Creator 
3T3 
3T3/NIH 
MCAT 
Mouse fibroblast 
DMEM + all 
(FCS) 
ATCC  
HA-g1  
(18 KlonXII) 
3T3/NIH 
MCAT 
Mouse fibroblast 
DMEM + all 
(FCS) 
Jörg 
Moelleken 
Myc-g2  
(24 Klon A41) 
3T3/NIH 
MCAT 
Mouse fibroblast 
DMEM + all 
(FCS) 
Jörg 
Moelleken 
HeLa-double5 
(SH4‐HASPB‐ 
GFP/SH4‐Yes‐ 
Cherry#5) 
HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
Julia 
Ritzerfeld 
HeLa-MCAT HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
Nickel 
Lab. 
HeLa-mcat-YFP-p24 HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
Andreas 
Max Ernst 
HeLa-mcat-YFP 
p24 (TMD)L17 
HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
Andreas 
Max Ernst 
HeLa Paris HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
Institute 
Curie 
HeLa DSMZ HeLa 
Human Cervical 
Cancer 
DMEM + all 
(FBS) 
DSMZ 
HEK293T HEK293T 
Human embryonic 
kidney 
DMEM + all 
(FBS) 
ATCC 
CHO CHO 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
ATCC 
C3-14 CHO 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
Christoph 
Rutz 
C3-30 CHO 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
Christoph 
Rutz 
C4-53 
 
CHO 
 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
Christoph 
Rutz 
Y3-9 CHO 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
Christoph 
Rutz 
Y4-9 
CHO 
 
Chinese 
Hamster Ovary 
DMEM + all 
(FBS) 
Christoph 
Rutz 
TABLE 2: List of cell lines used 
 
2.1.13. Molecular Biological and Biochemical Kits 
 
MBS Mammalian Transfection Kit   Stratagene (La Jolla, USA) 
Mycoplasma PCR Elisa Kit     Roche (Grenzach‐Wyhlen, 
Germany) 
NucleoSpin Plasmid      Macherey‐Nagel (Düren, 
Germany) 
QIAprep SPIN Miniprep Kit    Qiagen GmbH (Hilden, 
Germany) 
QIAgen Plasmid Maxi Kit     Qiagen GmbH (Hilden, 
Germany) 
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QIAquick Gel Extraction Kit    Qiagen GmbH (Hilden, 
Germany) 
QIAquick PCR Purification Kit    Qiagen GmbH (Hilden, 
Germany) 
Bio-Rad Protein Assay Bio-Rad Laboratories GmbH 
(Munich, Germany) 
BCA Protein Assay      Thermo Scientific Pierce 
(Illinois, USA) 
RNeasy Mini Kit      Qiagen GmbH (Hilden, 
Germany) 
The ImProm-II Reverse Transcription System Promega (Wisconsin, USA) 
 
2.1.14. Cell Culture Medium and Supplements 
 
Opti-MEM® I Reduced Serum Media       Life technologies (Darmstadt, 
Germany) 
Dulbecco's Modified Eagle Medium (DMEM) Biochrom (Berlin, Germany) 
L-Glutamine       Biochrom (Berlin, Germany) 
Fetal Calf Serum      PAA Laboratories GmbH 
(Cölbe, Germany) 
Fetal Bovine Serum PAA Laboratories GmbH 
(Cölbe, Germany) 
Penicilin/Streptomycin     Biochrom (Berlin, Germany) 
 
2.1.15. List of siRNA’s 
 
Subunit Ambion ID siRNA name 
Stock 
Concentration 
gamma1-COP 237500 115 30µM 
gamma1-COP 237501 116 30µM 
gamma1-COP  - Silencer select 30µM 
gamma2-COP s25643 Gamma2 30µM 
zeta1-COP s22427 Zeta1 30µM 
zeta2-COP s27712 Zeta2 30µM 
alpha-COP 146404 Alpha 30µM 
delta-COP 10234 Delta 50µM 
beta-COP s3371 Beta 50µM 
GFP AM4626 GFP 50µM 
Scrambled siRNA - Scrambled siRNA 50µM 
Qiagen all-star 
negative control 
Qiagen 
All-star negative 
control 
50µM 
Subunit Dharmacon ID Lot # 
Stock 
Concentration 
gamma1-COP L-019138-00 100301 50µM 
gamma2-COP L-019988-01 100301 50µM 
zeta2-COP L-021116-01 100301 50µM 
p24-TMED2 J-008074-09 - 20µM 
TABLE 3: List of siRNA’s used 
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2.1.16. List of Primers 
 
PFB  
Forward           5’-CGA ACC CCA GAG TCC CGC TCA-3’ 
Forward new  5’-TGG AGA CTA AAT AAA ATC TT-3’ 
Reverse           5’- GGC TGC CGA CCC CGG GGG TGC-3’ 
 
FGF4  
Forward  5’-TTG GAT CCG CCA CCA TGG-3’ 
Reverse 5’-TTG CGG CCG CTT ACT TGT ACA GCT CGT CCA 
TG-3’ 
AgeI@599mut  
Forward 5’-CGC TAG CGC TAG CGG TCG CCA CCA TG-3’ 
Reverse 5’-CAT GGT GGC GAC CGC TAG CGC TAG CG-3’ 
 
DRONPA-AgeI  
Forward 5’-ATA TCT ACC GGT AAT GGT GAG TGT GAT TAA 
ACC-3’ 
Reverse 5’-GAT ATG AAT TCA GCT TGG CCT GCC TCG GCA 
GCT CAG -3’ 
 
HindIII(BamHI)-p23 
Reverse 5’-GCC GCA AGC TTT TAC TCT ATC AAC TTC -3’ 
 
NotI(BamHI)-p23 
Reverse 5’-GCC GCG CGG CCG CTT ACT CTA TCA ACT TC-3’ 
 
EcoRI-linker2 
Forward  5’-AAT TCA TCC GGA CTC AGS TCT CGA GCT CAA 
GCT TCG -3’ 
Reverse 5’-AAT TCC GAA GCT TGA GCT CGGA GAT CTG AGT 
CCG GAT G-3’ 
 
2.1.17. Software’s 
 
ZEN 2009 and 2010 Carl Zeiss Jena GmbH (Jena, 
Germany) 
Fiji 1.46j      ImageJ (NIH, USA) 
Volocity 5.2.1 Perkin Elmer (Massachusetts, 
USA) 
Graphpad Prism 5 GraphPad Software, Inc. 
(California, USA) 
DNA Strider 1.4f6     CEA (France) 
4Peaks,Version 1.7.2 (1.7.1)    Mek&Tosj (Amsterdam, The 
Netherlands) 
Image Studio       LI-COR Biosciences GmbH 
(Bad Homburg, Germany) 
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2.1.18. Technical Devices 
 
Instead of the once which are mentioned specifically, commonly used 
chemicals and consumables were purchased from the listed companies below. 
Infors AG (Einsbach), Braun (Melsungen), Eppendorf (Hamburg), Kendro 
(Langenselbold), Zeiss (Göttingen), Becton Dickinson (Heidelberg), 
PerkinElmer (Massachusetts, USA), Bio‐Rad Laboratories GmbH (München), 
Peqlab (Erlangen), Gilson (Villiers‐le‐Bel,France), NeoLab (Mannheim).  
 
2.1.19. Buffers 
 
PBS (10X) 
1,37 M NaCl 
43 mM Na2HPO4x2H2O 
27 mM KCl 
15 mM KH2PO4 
 pH = 7.4 
 
PBS-T 
1X PBS 
0,05% (v/v) Tween-20 
 pH = 7.4 
 
Lysis Buffer I (for siRNA knockdown experiments) 
1X PBS 
1% (w/v) TritonX100  
Protease Inhibitor Cocktail tablet (freshly added) 
 
Lysis Buffer II 
20 mM HEPES 
100 mM NaCl 
5 mM EDTA 
0.5% Sodium Deoxycholate 
1% TritonX100 
 pH 7.4 
Protease Inhibitor Cocktail tablet (freshly added) 
 
Lysing Buffer III (containing 4% octylglucoside)  
20 mM HEPES 
50 mM NaCl 
4% Octylglucisidase (n-octyl-β-D-glucoside) 
 pH 6.8 
 
PBS/EDTA 
1:1000 EDTA (stock concentration: 0.5 M   pH 7.8) in PBS 
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5X DNA Loading Buffer 
0.25% (w/v) Bromophenol blue 
30% (w/v) Glycerol 
10 mM Tris-HCl pH 8.0 
 
50X TAE 
40 mM Tris-HCl 
20 mM Acetic Acid 
1 mM EDTA 
 pH 8.0 
 
4X SDS Loading Buffer 
200 mM Tris-HCl pH 6.8 
40 % (v/v) Glycerol 
12 % (v/v) β-mercaptoethanol 
8 % (w/v) SDS 
0.2 % (w/v) Bromophenol Blue 
 
SDS-page Running Buffer 
25 mM Tris 
192 mM Glycine 
0.1 % (w/v) SDS 
 
Blotting Buffer 
25 mM Tris 
250 mM Glycine 
20 % (v/v) Methanol 
 
IP Buffer I 
20 mM HEPES-KOH  
50 mM NaCl 
4% (w/v) Octyl glucoside (n-octyl-β-D-glucoside) 
 pH 6.8 
 
IP Buffer II 
25 mM Tris-HCl 
150 mM NaCl 
1 mM EDTA 
 pH 7.4 
 
Cultivation Medium (DMEM+all) 
10% (v/v) FBS 
2 mM L-Glutamate 
100 units/ml Penicillin 
100 µg/ml Streptomycin 
 
Freezing Medium 
40% FBS 
10% DMSO 
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in DMEM + all 
 
Sorting Medium 
5% Cell Dissociation Buffer 
0.2% FBS 
2 mM L- Glutamate 
100 units/ml Penicillin 
100 µg/ml Streptomycin 
in DMEM 
 
2.2. Methods 
 
2.2.1. Molecular Biological Methods 
 
2.2.1.1. Polymerase Chain Reaction (PCR) 
 
PCR Reaction I 
100 ng  DNA template 
1 µl   Forward Primer (10 pmol/µl) 
1 µl   Reverse Primer (10 pmol/µl) 
1 µl   dNTP’s (10 mM each) 
5 µl   10X Pfu Buffer 
1 µl   Pfu Turbo Polymerase (2.5 u/µl) 
Up to 50 µl   H2O 
 
PCR Reaction II 
100 ng  DNA template 
1 µl   Forward Primer (10 pmol/µl) 
1 µl   Reverse Primer (10 pmol/µl) 
1 µl   dNTP’s (10 mM each) 
5 µl   MgCl2 (25mM) 
5 µl   10X Buffer 
1 µl   Taq Polymerase  
Up to 50 µl   H2O 
 
According to the polymarease, which was chosen, one of the two standard PCR 
reactions above were used to amplify or introduce a particular piece of DNA 
sequence. 
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PCR program 
Start   98°C  5 min  
 
Denaturation 98°C  30 sec 
Hybridization 60°C  30 sec                 Amplification (30 cycles) 
Elongation 72°C  1 min/kb target gene 
 
End   72°C  5 min 
Store  4°C  ∞ 
 
2.2.1.2. PCR Purification 
 
Using QIAquick PCR Purification Kit the PCR products were purified and DNA 
was eluted in 50 µl H2O. 
 
2.2.1.3. Site-Directed Mutagenesis 
 
Site-directed mutagenesis was used to do point mutations in the gene of 
interest.  
PCR Reaction 
100 ng  DNA template 
1 µl   Forward Primer (100 pmol/µl) 
1 µl   Reverse Primer (100 pmol/µl) 
1 µl   dNTP’s (10 mM each) 
5 µl   10X Pfu Buffer 
1 µl   Pfu Turbo Polymerase (2.5 u/µl) 
Up to 50 µl   H2O 
 
PCR Program 
Start   98°C  2 min  
 
Denaturation 98°C  30 sec 
Hybridization 50°C  1 min      Amplification (18 cycles) 
Elongation 68°C  10 min  
 
End   68°C  15 min 
Store  4°C  ∞ 
 
After the polymerase chain reaction DpnI treatment followed for 2 h at 37°C. 2 
µl DpnI enzyme was added to each reaction. 
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2.2.1.4. Restriction Digest 
 
Standard Reaction (total volume 50 µl) 
DNA     1 µg 
Restriction Enzyme  1 µl (10 U) 
10X NEBuffer   5 µl (1X) 
BSA (if necessary)   add to a final concentration of 100 µg/ml (1X) 
H2O     up to 50 µl 
 
In a common reaction the incubation time is 1 h and the temperature is 37°C. 
Depending on the enzyme(s) used for the restriction endonuclease digest, 
incubation time and incubation temperature were defined.  
 
2.2.1.5. Ligation of DNA Fragments 
 
Ligation of DNA fragments were performed by catalyzing the formation of the 
phosphodiester bonds between the strands with the enzyme called T4 DNA 
ligase. Ligation reaction was set according to the Ligation Equation below and 
incubated for either 1h at room temperature or overnight at 4°C.  
Ligation Equation 
Insert Size (bp)/Vector Size (bp) X Vector Amount (µg) X 5 = Insert Amount 
(µg) 
 
2.2.1.6. Heat Shock Transformation of Competent Bacteria 
 
100 µl of DHα5 E.coli competent cells were mixed with 2-5 µl ligation reactions 
and incubated on ice for 30 min. Heat shock is performed for 90 sec at 42°.  
Immediately after the heat shock, cells are places on ice for 10 min and 900 µl 
LB medium was added on the cells. Cells were incubated at 37°C with agitation 
for 1 h and centrifuged for 1 min at 13.000 rpm. Afterwards 900 µl of the medium 
is discarded. Sedimented cells were resuspended with remaining medium and 
plated on an agar plate containing appropriate antibiotic and allowing the 
colonies to grow overnight at 37°C.  
 
2.2.1.7. Plasmid Preparation from Bacteria 
 
The method was used to extract and purify DNA of interest from E.coli. Growth 
31 
 
of the bacteria was allowed in LB medium supplemented with antibiotics 
(Ampicilin or Kanamycin) according to the plasmid selection marker. Plasmid 
DNA was extracted and purified using Qiagen Kits according to manufacturer’s 
instructions. DNA was eluted in desired amount of H2O and DNA concentration 
was determined by NanoDrop ND‐1000 spectrophotometer. 
 
2.2.1.8. Agarose Gel Electrophoresis 
 
Agarose gel electrophoresis was used to separate the DNA fragments. 1% 
agarose gel was prepared by solving the 0.5 g Agarose NEEO Ultra-Qualität 
(Roth, Germany) in 50 ml 1X TAE buffer. After cooling down, Ethidium Bromide 
was added for detection of DNA to final concentration of 0.5 μg/ml. Gel was 
poured into gel cast for solidification and combs were inserted to create wells 
for loading samples.  
 
Samples were mixed with 5X DNA Loading Buffer and loaded in the wells of 
the 1% agarose gel. In addition to the samples, 1 kb DNA Ladder was loaded 
on a gel as a reference of size of the DNA fragments. Electrophoresis was 
performed in 1X TAE Buffer with 100 V to separate the samples in PeqLab Gel 
Chamber. DNA bands were visualized in BioRad Gel Doc 2000 under 260 nm 
UV light.  
 
2.2.1.9. Gel Extraction 
 
DNA containing bands of the 1% agarose gel were cut. DNA was extracted by 
using Qiagen Gel Extraction Kit according to manufacturer’s instructions.  
 
2.2.1.10. DNA Sequencing  
 
The prepared DNA sent to the company called GATC Biotech AG (Konstanz, 
Germany) for determining the order of nucleotides. DNA sequences sent by the 
company were compared to theoretical sequences by DNA Strider and 4Peaks 
software’s.  
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2.2.1.11. Alcohol precipitation  
 
Precipitation of the DNA was done by adding 3 M sodium acetate pH 5.0, 1:10 
volume of the DNA and 2.5X 100% EtOH. DNA was incubated at -20°C for 20 
min. Centrifugation followed for 15 min at 13.000 rpm. The pellet was washed 
with 70% EtOH and spun down again at 13.000 rpm only for 5 min. And the 
pelleted DNA was resuspended with H2O.  
 
2.2.1.12. Glycerol stock preparation 
 
After the heat shock transformation the bacteria containing desired plasmids 
were stored in glycerol stocks. 800 µl of inoculated bacteria in LB medium with 
200 µl of autoclaved 80% Glycerol were mixed immediately and snapped freeze 
in liquid nitrogen. Stored at -80°C.   
 
2.2.1.13. Determination of DNA-concentration 
 
DNA concentration was determined by NanoDrop ND‐1000 
spectrophotometer. 1-2 µl DNA was measured with 260 nm wavelength.  
 
2.2.1.14. Cell Culture Techniques 
 
2.2.1.14.1. Maintenance of the Adherent Cells 
 
Adherent cells were cultivated in petri dishes of various sizes in an appropriate 
medium at 37°C with 5% CO2. When the cells reached to 95-100% confluency 
the cells were passaged to continue normal growth. For passaging the cells, 
the growth medium was discarded. Cells were rinsed with PBS and dissociated 
from the petri dishes by adding ~1 ml Tyripsin/EDTA (for 10 cm petri dish) and 
incubating at 37°C for 3-5 min. Fresh medium added onto tyripsinized cells and 
plated on desired amount of cell to a new petri dishes. The cells were incubated 
in 37°C with 5% CO2 for normal growth.  
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2.2.1.14.2. Freezing cells 
 
Cells were grown in 10 cm petri dishes until the 80-90% confluency. Rinsed 
and tyripsinized as explained above. 10 ml fresh medium is added and the cells 
were collected in 15 ml conical tube. Centrifugated cells for 3-5 min at 1000 
rpm were pelleted. Tyripsin containing medium was discarded and the pellet 
was resuspended with 1.5 ml freezing medium. Cells were placed into cryo vials 
and stored at -80°C. For long-term storage cryo vials were placed into liquid 
nitrogen tanks.  
 
2.2.1.14.3. Thawing cells 
 
Frozen cells in the cryo vials were immediately placed in 37°C water bath for 
fast thawing. Cells were transferred to a 50 ml conical tube containing pre-
warmed 20 ml growth medium. Cells were centrifuged for 5 min at 1000 rpm 
and the medium was discarded. Pelleted cells were gently mixed with fresh 
medium and plated in a petri dish. Cells were incubated at 37°C with 5% CO2 
for normal growth. 
 
2.2.1.14.4. Transient Transfection of Mammalian Cells 
 
Method was used for expressing exogenous DNA in mammalian cells. Cells 
were plated into petri dishes or 6-well plates in 60-70% confluency 24 h prior to 
the transfection. Lipofectamine or Fugene were used to transiently transfect 
plasmid DNA to mammalian cells according to manufacturer’s instructions.  
 
2.2.1.14.5. Retroviral Transduction of Mammalian Cell Lines 
 
Generating stable cell lines was performed by retroviral transfections. For 
retroviral transfection of the mammalian cell lines, the MBS Mammalian 
Transfection Kit (Stratagene) was used according to manufacturer’s 
instructions.  Plasmid containing retroviral particles were produced in HEK293T 
cell lines with help of two vectors (pVPack‐GP and pVPack‐Eco) and the 
plasmid. Supernatant containing viral particles was used for transduction of the 
HeLa-MCAT cell lines. 48-72 h after transduction the cells were sorted for 
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Doxycycline inducible reporter gene expression from the pRev-TRE2 vector by 
several rounds of FACSAria flow cytometer sorting.   
 
2.2.1.14.6. Fluorescence‐Activated Cell Sorting (FACS) 
 
FACS sorting was used to select the cells stably expressing the reporter 
proteins in a doxycycline inducible manner. Cells were plated 48 h prior to the 
sorting and 24 h before the sorting 1 µg/ml doxycycline was added or not (for 
“bright” or “dark” sorting, respectively). Cells were washed with PBS and 
detached from the dish using Cell Dissociation Buffer. Cells were collected with 
Sorting Medium and passed through a cell strainer cap (Becton Dickinson). 
FACSAria flow cytometer was used sort the cells according to the expression 
of the reporter proteins fluorescence characteristics. To collect a pool of cells 
which expresses the reporter protein in a tightly doxycycline inducible manner, 
the cells were subjected to subsequent three sorting, namely, bright, dark and 
bright sort. First sorting was for the fluorescent cells, which was induced with 
doxycycline. Second sort were uninduced cells, which don’t expressed the 
reporter protein. This sort was for separating the leaky cells expressing the 
reporter protein in the absence of doxycycline. And the final sort was bright sort 
with induced cells lead to a pool of doxycycline-induced cells. 
 
2.2.1.14.7. siRNA Transfection of Mammalian Cells 
 
Adherent HeLa cells were siRNA transfected using Oligofectamine transfection 
reagent in 6-well plates. Cells were plated on 6-well plates 24 h prior to the 
transfection in 60% confluency. Following day, 50 pmol siRNA (30-50 µM) was 
diluted in 180 µl Opti-MEM and mixed with 48 µl Oligofectamine diluted 1:4 in 
Opti-MEM (12 µl Oligofectamine, 36 µl Opti-MEM). This siRNA and 
oligofectamine mixture was incubated for 20 min at room temperature. While 
this mixture was incubated, cells were washed with oligofectamine and 1.5 ml 
fresh oligofectamine were added in each well. Afterwards, siRNA-
Oligofectamine mixture is slowly added to each well while gently mixing the 
plate. Cells were incubated for 4 to 6 hours at 37°C and medium was 
exchanged with a normal growth medium. 24 h after transfection cells were split 
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to suitable dishes for microscopy, in addition to fresh 6-well plates. In the case 
of doxycycline induction, cells were incubated the last 24 h in the presence of 
1 µl/ml doxycycline at 37°C.   
 
2.2.1.15. Fluorescence Microscopy Techniques 
 
2.2.1.15.1. Wide-field and Confocal Microscopy 
 
Imaging of the cells was performed with wide-field or confocal microscopes. 
Live cell imaging is performed with imaging medium containing HEPES and 
fixed cells were subjected to immunofluorescence staining. Axiovert 200M 
fluorescence microscope (Zeiss), LSM 510 confocal microscope (Zeiss), LSM 
780 confocal microscope and Perkin–Elmer Ultra-view spinning disk confocal 
microscope were used for imaging.  
 
2.2.1.15.2. Immunofluorescence Labeling 
 
Cells were plated on a Mattek dishes or cover slips for microscopy. Cells were 
fixed with 4% paraformaldehyde for 20 min following the quenching with 50 mM 
ammonium chloride for 15 min cells were blocked with 5% BSA for 15 min. After 
that cells were subjected to primary and secondary antibodies subsequently for 
30 min at room temperature. Between all the steps cells were rinsed with 1X 
PBS. Cover slips were mounted with DAPI containing The ProLong® Gold 
Antifade Reagent (Life Technologies). 
 
2.2.2. Biochemical Methods 
 
2.2.2.1. Cell Lysis for siRNA Knockdown Experiment 
 
Cells were placed on ice and rinsed with chilled 1X PBS. 500 µl PBS/EDTA 
added on and the cells were scraped. Collected cells in eppendorf tubes were 
centrifuged at 200 g for 3 min at 4°C. The pellet was resuspended in 80 µl 
PBS/TritonX100/Protease Inhibitor Cocktail and lysed by vortexing every 10 
min for 30 min. Afterwards cells were agitated with sonification for 5 min and 
centrifuged at 14.000 rpm for 15 min at 4°C. Supernatant was subjected to BCA 
protein determination. During the whole procedure the cells were kept on ice.  
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2.2.2.2. Cell Lysis 
 
Cells were placed on ice and rinsed with chilled PBS. For 10 cm petri dishes 
800 µl PBS added to the cells and cells were scraped. Collected cells were 
centrifuged at 6500 rpm for 5 min at 4°C. The pellet was resuspended with 100 
µl Lysis Buffer II and agitated on overhead rotator at 4°C for an hour. Cells were 
centrifuged at 6500 rpm for 5 min at 4°C. Lysate was subjected either to SDS-
page analysis or immune precipitation.  
 
2.2.2.3. Protein Concentration Determination 
 
Two different methods were used to determined protein concentrations in the 
cell lysates or tissue samples namely; Bradford and BCA assays. For Bradford 
assay Bio-Rad Kit from Bio-Rad and for BCA assay BCA Protein Assay Kit from 
Thermo Scientific Pierce were used according to manufacturer’s instructions. 
 
2.2.2.4. In vivo Crosslinking  
 
DSG (Disuccinimidyl glutarate) was used for in vivo crosslink experiments with 
stable cell lines expressing protein of interest in Doxycycline inducible manner. 
30.104 cells/well plated in a 6-well plate and incubated for 24 h with 1 µg/ml 
doxycycline. Cells were washed with PBS and incubated with the permeable 
cross-linker DSG (0.5 mM in 5 µl DMSO) in PBS for 15 min at room 
temperature. After cross-linking, cells were quenched with 100 mM Glycine pH 
3 and 500 mM Tris pH 8 subsequently for 15 min each at room temperature. 
Cells were washed with PBS and lysed as described in “Cell Lysis” previously. 
The lysate was heated at 65°C for 10 min in sample buffer containing 50 mM 
DTT (freshly added). Samples were subjected to SDS-PAGE analysis and 
western blotting. 
 
2.2.2.5. Immune-precipitation  
 
After 24 h incubation with doxycycline the cells were lysed according to “Cell 
Lysis” protocol described above. Fresh lysate was mixed with 20 µl Protein A 
beads (which was chosen according to the antibody) and 5 µl anti-GFP 
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antibody (Abcam) and incubated overnight at 4°C on an overhead rotator. The 
beads were washed for five times with 1 ml Lysis Buffer II and then eluted in 30 
µl sample buffer by boiling for 5 min at 95°C. Finally, the samples were analyzed 
with SDS-PAGE and western blot.   
 
2.2.2.6. SDS-Page (Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis) Analysis 
 
Proteins were separated according to their electrophoretic mobility. Lysed cells 
or tissue samples were SDS treated and run in defined gel compositions.  
Gels are consists of two different layers: Stacking gel and separating gel. 
Acrylamide concentration of the separating gel defines the gel structure. Also 
different acrylamide/bisacrylamide ratios can be used for special purposes.  
 
Stacking Gel 
 
Gel concentration 4% 
0.5 M Tris/HCl (pH 6.8) 2.5 ml 
H2O 6.1 ml 
Acrylamide 1.3 ml 
10% SDS 100 µl 
APS 100 µl 
TEMED 10 µl 
 
Separating Gel 
 
Gel concentration 6% 
1.5 M Tris/HCl (pH 8.8) 3.75 ml 
H2O 8.1 ml 
Acrylamide 3 ml 
10% SDS 150 µl 
APS 150 µl 
TEMED 15 µl 
 
Gels were polymerized in between two glass plates in a way the separating gel 
at the bottom and the stacking gel on top. Using combs, pockets were 
introduced allowing different samples to be loaded. Samples were diluted in 4X 
SDS Loading Buffer and boiled at 95°C for 5 min. Polymerized gels were placed 
in a gel chamber with Running Buffer and the samples were loaded in the wells. 
Along with the samples protein marker (Precision Plus Protein™ All Blue 
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Standards) was loaded to use as a standard of molecular weights. Chamber is 
securely closed and the electric field was applied to the gel, allowing the 
negatively charged molecules migrate through the gel matrix. Constant 100 V 
is applied until the front-dye reaches the end of the gel for proper separation of 
the proteins.  
 
2.2.2.7. Western Blot Analysis 
 
Separated proteins by SDS-Page transferred onto PVDF membranes 
(Millipore, Schwalbach) via “Wet-Blot” method. Assembly of the system 
requires filter papers, PVDF membrane, Methanol and Blot Buffer. Filter papers 
were soaked in blot buffer and the PVDF membrane was soaked first in 
methanol for activation and then in blot buffer for equilibration. From bottom to 
top components of the sandwich was placed in cassettes; sponge, two filter 
papers, polyacrylamide gel, PVDF membrane, again two filter papers and 
sponge. Closed the cassette carefully and placed it in a chamber. Put an 
icepack in the chamber to keep it cool and a stir bar for even distribution of the 
ions and the temperature. Closed the chamber securely and under constant 
voltage (for 0.75 mm thickness of the gels; 100 V for 1 h or 30 V for overnight) 
transferred the proteins to the PVDF membrane. The membrane containing 
proteins was ready to further process.  
 
2.2.2.8. Immune-blot Analysis 
 
Membranes were rinsed with PBS-T briefly and blocked with 5% milk in PBS-T 
for an hour at room temperature. Afterwards membranes were washed with 
PBS-T twice for 10 min and then incubated with primary antibodies in 1% BSA 
in PBS-T for 1 h at room temperature. The membranes were washed three 
times for 10 min at room temperature and incubated with secondary antibody 
in 1% BSA in PBS-T for 30 min at room temperature in dark. The membranes 
washed with PBS-T last three times for 10 min. All incubations in the procedure 
can be done at 4°C overnight. Detection of the membranes was performed by 
LICOR Odyssey as the manufacturer’s instructions.  
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3. Results 
 
Different aspects of vesicular transport in the early secretory pathway were 
investigated in this study. The classical secreted of cargo starts its journey 
where it is being synthesized and assembled (ER) and then continues in 
various transport carriers until it reaches its final destination. Unconventionally 
secreted proteins do not enter this pathway or skip some compartments along 
their way to their final destination (Nickel and Rabouille, 2009, Rabouille et al., 
2012). In the scope of this thesis, the following questions were addressed: i) 
Does the γ2-COP subunit play a role in the transport of unconventionally 
secreted SH4 domain containing proteins (HASPB and YES)?, ii)  Do novel 
analogues of the Arf1-GEF complex inhibitor of Brefeldin A affect the Golgi 
structure in the same way as BFA?, iii) Is the non-SM18 binding mutant of p24 
able to form an oligomeric state in vivo?, and iv) Are there differences in the 
kinetics of cycling within the early secretory pathway of the different members 
in the p24 family?  
 
3.1. CHAPTER I: Role of γ2-COP in the transport of SH4 domain 
containing proteins  
 
Genome-wide screens based on RNA interference suggest that the transport 
of SH4 domain containing proteins to the plasma membrane is dependent on 
coatomer isoforms (Walter Nickel and Rainer Pepperkok, unpublished). More 
specifically, knockdown of γ2-COP causes a secretion block of SH4 domain 
proteins, while a knockdown of γ1-COP does not affect the transport of the SH4 
domain proteins (Walter Nickel, unpublished). Based on these findings the 
association of SH4 domain containing proteins and the coatomer subunits is 
investigated in this chapter.  
 
Considering the preliminary data (Nickel Laboratory, BZH Heidelberg), stable 
cell lines were produced to express SH4 domain containing reporter proteins in 
3T3 cell lines with an established gamma subunit knockdown system.  These 
cell lines were created to further characterize the role of the γ-COP subunits in 
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the intracellular localization of the aforementioned reporter proteins HASPB 
and Yes.   
 
In addition to the generation of the cell lines, siRNA knockdown experiments 
were performed to investigate the effect of coatomer subunits on the 
intracellular localization of the reporter proteins.  
 
3.1.1. Generation and characterization of stable cell lines expressing 
SH4 domain containing proteins 
 
Doxycycline inducible stable 3T3 cell lines, as establish earlier in the Wieland 
Laboratory, were transduced with HA and myc tagged γ1-COP and γ2-COP 
(respectively) by retroviral transduction. These cell lines 3T3/rtTA-HA-hγ1 and 
3T3/rtTA-Myc-hγ2 will be shortened as 3T3g1 and 3T3g2, respectively in the 
context of this thesis (Joerg Moelleken, PhD thesis). When the cells were 
characterized, they were found unexpectedly to cause down regulation of the 
endogenous proteins while the respective exogenous γ-COP subunits was 
induced. This resulted in only one of the tagged γ-COP subunits being present 
in mouse fibroblast cell line 3T3 cells after 48 h induction. 
 
The 3T3g1 and 3T3g2 cell lines were then templates for the generation of new 
cell lines, constitutively expressing SH4 domain containing reporter proteins 
(SH4-proteins). The SH4-proteins Leishmania protein HASPB (Hydrophilic 
Acylated Surface Protein B) and human Src kinase Yes were used as reporters. 
The N-terminal 18 amino acids of HASPB and Yes containing the SH4 domain 
were fused to GFP and mCherry fluorescent proteins, respectively (Julia 
Ritzerfeld, PhD thesis), resulting in the constructs: SH4-HASPBN18-GFP and 
SH4-YesN18-mCherry. The fusion proteins were introduced into the 3T3 cells 
with a gamma subunit knockdown system by retroviral transduction. 
 
Constructs were created from the retroviral vector pRevTRE2 as described in 
the methods section. A different retroviral vector was chosen to be able to 
acquire constitutive expression of the reporter proteins. In addition to these 
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unconventionally secreted reporter proteins, the conventionally secreted FGF4 
fused to GFP protein was employed.  
 
Following retroviral transduction, HEK293T cells were cultivated for 48 h and 
then subjected to the Fluorescence Activated Cell Sorting (FACS). Cell 
populations are displayed in dot plots; the X-axis represents Forward Scatter 
(FSC) and the Y-axis represents relative fluorescent intensity (Figure 1). A 
threshold was set according to expression levels in the negative control cells, 
not expressing GFP, and positive control cells only expressing GFP. Only cells 
with a signal intensity above the threshold 102 were selected in a pool, since 
these cells were expressing the fluorescent-tagged exogenous proteins.   
 
 
FIGURE 1: Sorting of the stable cell lines by FACS. Stable cell lines expressing 
the reporter proteins: HASPB, Yes and FGF4, fused to fluorescent tags were 
generated and sorted by FACS. Non-GFP expressing negative and GFP-only 
positive control cells were used to set the threshold for the fluorescence intensity. 
The selected cells were then pooled for further experiments.   
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Employing the same experimental flow, six different stable cell lines were 
created and are listed in Table 4.  
 
Name of the Cell Line Cell line Origin 
3T3g1-FGF4-GFP 
3T3/NIH Mouse fibroblast 
3T3g1-SH4-HASPBN18-GFP 
3T3g1-SH4-YesN18-mCherry 
3T3g2-FGF4-GFP 
3T3g2-SH4-HASPBN18-GFP 
3T3g2-SH4-YesN18-mCherry 
 
TABLE 4: List of Generated Cell Lines.  
 
3.1.2. Characterization of the stable cell lines 
 
Stable cell lines expressing reporter proteins were characterized by 
fluorescence microscopy and immune-precipitation. 
 
 
FIGURE 2: Localization of the exogenous SH4-proteins in 3T3g1 and 3T3g2 
cell lines. Cell lines expressing HASPB-GFP, Yes-mCherry and FGF4-GFP were 
induced with doxycycline and visualized by fluorescence microscopy. GFP 
excitation: 488 nm, Cherry excitation: 560 nm.  
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When the cells lines were examined with confocal microscopy, homogenous 
expression of the reporter proteins was observed at low magnification (data not 
shown).  Examination with high magnification, however, showed plasma 
membrane localization of HASPB-GFP and Yes-mCherry fusion proteins 
(Figure 2, A-D). FGF4-GFP was localized partially to the nucleus and partially 
at the cytosol (Figure 2, E-F). FGF4 was not found at the plasma membrane. 
As FGF4 is known to be secreted into the medium, its concentration in the 
exocytic pathway was probably too low to be detected.   
 
In summary, in six different stable 3T3 cell lines expressing the SH4-proteins 
fused to fluorescent reporter proteins were localized at the plasma membrane. 
 
3.1.2.1. Intracellular localization of the SH4-proteins in 3T3 cell lines 
 
Expression of HASPB and Yes was induced under conditions where only one 
γ-COP subunit was expressed. Cells were treated with doxycycline for 24 h, 48 
h and 72 h and the localization of the reporter proteins was visualized by 
confocal microscopy. Doxycycline induced cells display plasma membrane 
localization of the reporter proteins HASPB and Yes, and nuclear and cytosolic 
localization of FGF4, similar to the non-doxycycline treated control cells (data 
not shown).  
 
3.1.2.2. Monitoring the gamma knockdown system in 3T3 cell lines 
 
Stable cell lines were also analyzed biochemically to examine if the property of 
template cell lines were altered during generation of the new stable cell lines. 
In 3T3g1-HASPB-GFP and 3T3g2-HASPB-GFP cell lines γ-COP levels were 
detected by immune precipitation after doxycycline induction for 24 h, 48 h and 
72 h. 
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FIGURE 3: Immune-precipitation of γ1- and γ2-COP proteins from 3T3g1- and 
3T3g2-HASPB-GFP cell lines. 500 µg total protein of doxycycline treated cell 
lysates were immune-precipitated with CM1-antibody (recognizing native coatomer). 
Due to a technical error, only 25% of the 24 h and 48 h samples were loaded to 6% 
SDS-PAGE gel and analyzed by western blotting with a gamma-r antibody 
(recognizing γ1-COP and γ2-COP). 
 
As shown in Figure 3, uninduced cells express both γ1- and γ2-COP subunits 
in similar amounts. On the other hand, the doxycycline treated cell lines exhibit 
expression of only one of the subunits. The amount of protein appears to be 
increased after 72 h of induction; which is due to a loading error. This result 
shows that the characteristics of the template cells remained while the stable 
cell lines were co-expressing HASPB-GFP.  
 
3.1.3. siRNA knockdowns of coatomer subunits in HeLa cells 
 
HeLa SH4‐HASPBN18‐GFP/SH4‐YesN18‐Cherry Clone#5 (HeLa double5) 
stable cell lines, which in a doxycycline dependent manner simultaneously 
express fluorescently tagged HASPB and Yes were provided by Dr. Julia 
Ritzerfeld. Preliminary data from the Nickel Laboratory indicated that SH4 
domain containing reporter proteins accumulated in perinuclear regions instead 
of locating to the plasma membrane, when γ2-COP was knocked down in HeLa 
double5 cells. This implied that proper targeting of these unconventionally 
secreted reporter proteins could depend on one of the γ-COP subunits. 
Therefore the intracellular localization of the SH4-proteins was investigated. 
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3.1.3.1. Effect of β, δ and α subunits on transport of SH4-proteins 
 
HeLa double5 cells were treated with doxycycline for 24 h and then transfected 
with siRNAs directed against various coatomer subunits. Scrambled siRNA and 
siRNA against GFP were used as controls, as well as mock treatment and non-
treated cells. After transfection, cells were split for biochemical and microscopic 
analysis to determine knockdown efficiency. Cells were lysed with lysis buffer 
containing 1% TritonX100. 60 µg of cell lysates were loaded in each lane of 4-
12% Bis-Tris Nu-PAGE gel. Western blot was performed using antibodies 
against coatomer subunits, GFP and, as loading control, against GAPDH.  
 
β- and δ-COP siRNA transfections are shown in Figure 4. Untreated and mock 
treated cells showed comparable levels of β-, δ-COP and GFP protein. The 
housekeeping protein GAPDH was chosen as loading control for all lanes. With 
GFP siRNA, serving as positive control, 90 percent of the protein was silenced. 
With siRNAs targeting β- and δ-COP, the respective protein levels were 
significantly decreased (Figure 4, red star), while the control samples 
(scrambled, GFP siRNA and mock, non-treated cells) did not show altered 
protein levels of the coatomer subunits. In addition, when β-COP was knocked 
down, δ-COP levels also decreased. Since coatomer is a multi-protein 
complex, down regulation of one subunit (β-COP) also caused a loss of another 
subunit (δ-COP). Taken together, siRNA knockdowns of β- and δ-COP resulted 
in significant depletion of the respective proteins. 
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FIGURE 4: β- and δ-COP siRNA knockdown of HeLa double5 cell line. siRNA 
knockdown cells were lysed and 60 µg protein was loaded in each lane of the 4-12% 
Bis-Tris Nu-PAGE gel. Western blot was performed using antibodies against β-COP, 
δ-COP, GAPDH and GFP. 
 
Quantification of the knock down is shown in Figure 5. All bands were 
normalized first to the loading control and then to the mock treated cells. The 
normalized results show 60-80% decrease in the amount of the targeted 
protein. A similar knockdown efficiency of coatomer subunits was observed in 
repetitions of the experiments (n=7).  
 
 
FIGURE 5: Quantification of siRNA knockdown in HeLa double5 cell line. HeLa 
cells were knockdown with siRNAs against GFP, β-COP and δ-COP. Mock 
treatment and scrambled siRNAs were used as negative controls. All the bands were 
normalized to the loading control GAPDH first, and then to the mock treatment 
(Figure is a representative of n=7). 
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In addition to the biochemical analyses, cells were prepared for microscopy. 
Fixing the cells with different concentrations of paraformaldehyde (PFA) 
resulted in loss of fluorescence; therefore cells were imaged live by confocal 
microscopy. As also shown by western blot, GFP fusion protein expression was 
down regulated by the GFP siRNA (Figure 6, G). In untreated cells, SH4-
proteins HASPB and Yes localized to the plasma membrane and the same was 
observed for mock and scrambled siRNA treated cells. Transfection with β- and 
δ-COP siRNAs, however, resulted in perinuclear accumulation of HASPB-GFP, 
while Yes-mCherry was localized mainly to the plasma membrane. 
Furthermore, β- and δ-COP siRNA transfected cells displayed altered cell 
morphology: cells were more elongated in comparison to control cells (Figure 
6). Additionally, a siRNA knockdown against α-COP was performed. This 
knockdown resulted in down regulation of α-COP, and resulted in perinuclear 
accumulation of HASPB, while Yes was mainly localized to the plasma 
membrane (data not shown).  
 
 
FIGURE 6: Immunofluorescence of siRNA knockdown HeLa double5 cells. 
Cells were treated with siRNAs against the subunits of the coatomer indicated and 
induced with doxycycline for expression of the reporter proteins. Following 24 h 
induction cells were visualized by confocal microscope.  
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3.1.3.2. Effect of different ζ-COP isoforms on transport of the SH4-
proteins 
 
As preliminary data from the Nickel Laboratory implied, only one of the γ 
subunits of coatomer was affecting the transport of the SH4-proteins to the 
plasma membrane. In order to probe isoform specific effects on the transport 
of the SH4-porteins, other isoform specific coatomer subunits ζ1- and ζ2-COP 
were investigated.  
 
ζ1-COP and ζ2-Cop siRNA knockdown experiments were performed according 
to the same protocol and blotted for GAPDH, GFP, ζ1- and ζ2-COP antibodies. 
As depicted in Figure 7, the GAPDH amount indicates comparable loading of 
all lanes. Treatment with GFP siRNA resulted in more than a 90% reduction in 
the level of GFP protein. ζ1-COP level was already low in the control cells. Upon 
siRNA treatment a 70% reduction of ζ1-COP was observed. Surprisingly, ζ2-
COP was not detectable in HeLa double5 cells.  
 
 
FIGURE 7: siRNA knockdown of ζ-COP subunits in HeLa double5 cell line. 
siRNA knockdown cells were lysed and 60 µg of protein was loaded in each lane of 
4-12% Bis-Tris Nu-PAGE gel. Western blot analysis was performed using antibodies 
against GAPDH, GFP and Zeta-r (recognizing both ζ-COP subunits).  
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Therefore, quantitative real time PCR (qRT-PCR) was performed to quantify 
the mRNA level of ζ2-COP, indicating that HeLa double5 cell lines contain only 
neglectable amounts of ζ2-COP mRNA (Figure 8), while the positive controls 
HepG2 and HEK293T cells show 42 and 10 fold higher quantities of ζ2-COP 
mRNA, respectively. 
 
FIGURE 8: Relative quantification of ζ2-COP mRNA levels. RNA was isolated 
from HeLa, Hek293-T and HepG2 cell lines and subjected to RT-PCR. Relative 
amounts of mRNA levels for ζ2-COP are compared.  
 
3.1.3.3. Effect of γ-COP isoforms on the transport of SH4-proteins 
 
To investigate the effect of γ subunits on the transport of the SH4-proteins, 
HeLa double5 cells were transfected with siRNAs against γ subunits of 
coatomer. For γ1-COP, three different siRNAs were used: G1-115, G1-116 and 
G1-si (Table 3). Cell lysates were subjected to 6% SDS-PAGE gels with a 
Bisacrylamide to Acrylamide ratio of 1:100 (instead of the usual 30%) for better 
separation of γ1- and γ2-COP. Western blots were performed using antibodies 
against γ-COP (anti-gamma-r) and α-COP (anti-alpha-COP).  
 
Figure 9 illustrates that untreated, mock treated and cells treated with 
scrambled siRNA display similar amounts of γ1- and γ2-COP. The recombinant 
coatomer sample shows similar amounts of protein in positive control 
treatments for the two γ-COP subunits (Figure 9, Lane 10). G1-116 and G1-si 
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siRNAs down regulated γ1-COP in the cells, while G1-115 siRNA was not 
affecting the γ1-COP amount in the cell (Figure 9, Lane 6-8). In the case of γ2-
COP, G2-si siRNA down regulated the protein successfully (Figure 9, Lane 9). 
The knocked down cells were subjected to microscopy for possible effect on 
their phenotype.  
 
 
FIGURE 9: γ-COP siRNA knockdown in HeLa double5 cell line. Cells were 
treated with different siRNAs against γ subunit of coatomer for 48 h. Cell lysates 
were loaded on 4-12% Bis-Tris Nu-PAGE gel. Western blot was performed using 
antibodies against γ subunit (gamma-r antibody recognizing γ1- and γ2-COP) and 
α subunit.  
 
Cells were also analyzed by microscopy to visualize the effect of both ζ- and γ-
COP siRNA knockdowns. As depicted in Figure 10, cell morphologies of mock 
and scrambled siRNA treated cells were indistinguishable from the control cells. 
HASPB-GFP and Yes-mCherry localized mainly to the plasma membrane 
(Figure 10, A-D). However, transfection with ζ1-COP siRNA severely altered 
the morphology (Figure 10, E-F). Cells were elongated and an accumulation of 
HASPB-GFP in the perinuclear region was observed (Figure 10, E). However, 
Yes-mCherry localization to the plasma membrane was not compromised in 
the absence of ζ1-COP (Figure10, F). Since no ζ2-COP was detectable in HeLa 
double5 cell lines, knockdown of ζ1-COP results in retention of the HASPB-
GFP. Accordingly, ζ2-COP siRNA knockdown cells were not affected, i.e. 
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HASPB-GFP and Yes-mCherry were localized to the plasma membrane 
(Figure 10, E-H). γ1-COP siRNA knockdown cells were not morphologically 
altered and transport of the reporter proteins to the plasma membrane was not 
affected by the knockdown (Figure 10, I-P). G1-115 siRNA knockdown shows 
a very low amount of accumulation of the SH4-proteins at the perinuclear 
region, but compared to mock treatment and scrambled siRNA controls it was 
not significantly altered (Figure10, I-J). Likewise G2-si siRNA knockdown 
shows no phenotype (Figure 10, O-P).  
 
FIGURE 10: γ- and ζ-COP siRNA knockdown in HeLa double5 cell line  siRNAs 
against γ- and ζ-COP subunits of coatomer were used to knock down the respective 
proteins in HeLa cells,  and the cells were analyzed by fluorescence microscopy. 
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Altogether, knockdown of common coatomer subunits resulted in pronounced 
retention of the SH4-HASPB-GFP at the perinuclear region, suggesting that 
coatomer is involved in the transport of the SH4 domain containing reporter 
protein HASPB to the plasma membrane. However, knockdown of either γ1- or 
γ2-COP subunits do not individually affected the transport of reporter proteins.  
 
3.2. CHAPTER II: Impact of Brefeldin A analogues on Golgi 
morphology 
 
The chemical compound Brefeldin A (BFA) has been established in preventing 
transport by blocking the assembly of vesicular coats (Berger et al., 1993; 
Helms and Rothman, 1992a; Klausner et al., 1992; Lippincott-Schwartz et al., 
1990). The molecular target of BFA is the guanine exchange factor (GEF) 
interaction with Arf1. This interaction is important in cancer research as it is 
highly cytotoxic (Ohashi et al., 2011). Analogues of this compound were 
synthesized by the Helmchen Laboratory (Department of Chemistry, 
Heidelberg University). This chapter describes the effect of these analogues in 
mammalian cells in comparison to the original Brefeldin A.   
 
3.2.1. Effect of six novel Brefeldin A analogues in mammalian cell lines 
 
Initial experiments with BFA analogues are listed below (Table 5) and their 
chemical properties were described in detail in “Synthesis and Biological 
Properties of Novel Brefeldin A Analogues” (Förster et al., 2011). 
 
HeLa cells were used to monitor effects of BFA analogues on Golgi 
morphology. Cells were treated either with BFA or its analogues for 30 min and 
60 min at 37°C. Subsequently, the cells were incubated for 2 h in fresh medium 
after the treatment, in order to test for the reversibility of effects on the Golgi.  
Cells were subjected to immunofluorescence labeling with the cis-Golgi marker 
anti-GM130 and analyzed by spinning disk confocal microscopy.  
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 Brefeldin A 
 
   
No Name of the analogue Structure of the analogue 
1 (6R)-Hydroxy-Brefeldin A 
 
2 (7S)-Amino-Brefeldin C 
 
3 SF692 
 
4 SF687 
 
5 Brefeldin A-Lactamanalogue 
 
6 Brefeldin C-Lactamanalogue 
 
TABLE 5: Brefeldin A and the analogues 
 
When cells were treated with the compounds for 30 min, BFA treated cells show 
a disrupted Golgi apparatus, while control cells maintain an intact Golgi (Figure 
11). Similar Golgi disruption effects were observed with (6R)-hydroxy-BFA and 
BFA lactam analogue. At this time point, (7S)-amino-BFC, SF692, SF687, and 
BFC lactam analogues showed no effect on Golgi morphology.  
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FIGURE 11: Treatment of HeLa cells with Brefeldin A and the analogues. Cells 
were incubated with 1 µg/ml BFA and the analogues for the indicated times. As 
control, cells were incubated in medium without serum. Washouts were performed 
for 2 h in fresh medium after a 60 min incubation in the presence of the compounds. 
Golgi structure was visualized by the cis-Golgi marker anti-GM130 antibody.  
 
55 
 
When the time of exposure to the same (1 µg/ml) concentration of compound 
was extended to 60min, Golgi disruption effect was observed for (6R)-hydroxy-
BFA and BFA lactam analogue (Figure 11). Other derivatives at this 
concentration showed very weak effects or did not affect Golgi morphology at 
all.  
 
After 60 min treatment, the compounds were washed out for 2 h to probe for 
reversibility of the phenotypes. Golgi reassembly was observed in cells treated 
with (6R)-hydroxy-BFA and the BFA lactam analogue. The recovery of the 
Golgi disruption was slightly better for the BFA lactam analog in comparison to 
the BFA.  All fluorescence micrographs are depicted in Figure 11. 
 
Therefore, two substances, namely (6R)-hydroxy-BFA and BFA lactam 
analogue induce Golgi disassembly while the other four substances had no 
effect on Golgi morphology at 1 µg/ml after 30 min of treatment. The same two 
substances were also inducing Golgi disruption after 60 min, while the others 
did not. Following a 2 h washout, BFA lactam analogue resulted in a slightly 
better recovery then the (6R)-hydroxy-BFA. Following the washout, BFA lactam 
analogue treated cells were able to reverse the morphological changes in the 
Golgi at a level comparable with BFA. 
 
3.2.2. Effect of four novel Brefeldin A analogues in mammalian cell lines 
 
A second round of experiments were performed in collaboration with the 
Helmchen Laboratory with newly synthesized BFA analogues. Compounds 
were named as listed below (Table 6) and their chemical properties were 
described in detail in the manuscript “Synthesis and Biological Properties of 
Novel Brefeldin A Analogues” (Seehafer et al., 2013). 
 
HeLa cell lines were used again to observe effects on Golgi morphology. Cells 
were treated with BFA or analogues at a concentration of 5 µM for 30 min, 60 
min and a 2 h washout after the 60 min treatment. Effects were visualized with 
immunofluorescence microscopy.  
 
56 
 
Brefeldin A 
 
   
No Name of the analogue Structure of the analogue 
1 5 
 
2 39a 
 
3 39b 
 
4 39e 
 
TABLE 6: Brefeldin A and the analogues 
 
When the compounds were added to the cells for 30 min and the Golgi 
morphology was analyzed, all new compounds showed a partial Golgi 
disruption effect comparable to BFA (Figure 12). When the treatment was 
extended to 60 min for all compounds tested Golgi disassembly was observed, 
as shown in Figure 12.  
 
The Golgi reassembly capability was investigated after a 2 h compound 
washout with fresh medium after the 60 min treatment, shown in Figure 12. 
While Brefeldin A treated cells were able to recover after 2 h of washout, almost 
no recovery was observed in the cells treated with compound 5. Compound 
39a and 39b showed reassembly in almost only half of the cells. However the 
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compound 39e displayed a Golgi reassembly in a similar manner to Brefeldin 
A.  
 
FIGURE 12: Treatment of HeLa cells with Brefeldin A and the analogues. Cells 
were treated with 5 µM final concentration of the compounds for the times indicated 
or mock treated. 2 h washout experiments were performed after 60 min treatment 
with the compounds. Golgi structure was visualized by the cis-Golgi marker anti-
GM130 antibody.   
 
In summary, all the compounds were capable to affect Golgi morphology by 
total disruption. In addition, compound 39a and 39b were allowing a partial 
reassembly after washout, whereas only compound 39e was able to fully 
recover the disassembly effect of the substance. 
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3.3. CHAPTER III: Oligomerization of p24 and p24L17F 
transmembrane domains 
 
One of the major players of COPI coated vesicles are transmembrane proteins 
p24 family members. p24 family members form dimers and heterooligomers in 
addition to their monomeric forms. This equilibrium between inactive 
monomeric form and active oligomeric form of the p24 family members is 
suggested to be regulated by specific binding of SM 18 to the transmembrane 
segment of p24, as it was shown in vitro (Contreras et al, 2011). In order to test 
for the impact of SM 18 to p24, non-SM18 binding p24 variant (p24L17F) and 
wild-type p24 (p24 wt) were investigated in vivo.  
 
  
FIGURE 13: Western blot analysis of the expression of recombinant proteins. 
Stable HeLa cell lines were lysed after 24 h induction with doxycycline and western 
blot analyses was performed using an anti-p24 antibody (Elfriede, (Gommel et al., 
1999)).  
 
HeLa cells expressing YFP tagged p24 wild-type and p24L17F transmembrane 
domains in a doxycycline inducible manner were generated by Andreas M. 
Ernst. Since overexpression of the p24 family members results in 
mislocalization of the proteins, it was critical to determine the exact expression 
levels. To this end, cells were treated with doxycycline for different amounts of 
time to monitor exogenous expression in comparison to the endogenous 
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protein levels. For cell lysis, different detergents were evaluated to optimize the 
solubilisation of the membrane proteins (data not shown). Optimal conditions 
were observed with lysis buffer containing 4% octylglucoside, in accordance 
with previously established protocols for the analysis of p24 proteins (Jenne et 
al., 2002). Lysates were subjected to western blot analysis. 
 
As it is shown in Figure 13, HeLa mCAT cells were used as control, since these 
cells were the source of the stable cell lines. Endogenously expressed p24 
protein in the HeLa mCAT cells was observed in the blot, while ectopic 
expression of the tagged proteins was only observed in HeLa-YFP-p24 and 
HeLa-YFP-p24L17F lysates, together with endogenous p24 protein.  
 
After determining the expression of the recombinant p24 proteins, expression 
levels of these proteins were quantified after induction for 8 h and 24 h. After 
the incubation, cells were lysed and subjected to western blot analysis. The 
antibody against p24 protein (Elfriede, (Gommel et al., 1999)) was used for the 
western blot analysis, but the antibody also led to the detection of unspecific 
bands, evident in Figure 14. Endogenous p24 protein is observed in all the 
lysates together with p24 fusion proteins. Lysates of uninduced cells also show 
the p24 fusion proteins, which is probably due to leakage in the promoter. This 
leakage, however, can be ignored since it has no effect in the experimental set 
up and/or the outcome. When recombinant protein levels of uninduced cells are 
compared to those in induced cells (Figure 14, Lane 2 to 3, Lane 4 to 5, Lane 
6 to 7, and Lane 8 to 9) there is a clear increase in the amount of fusion protein. 
Furthermore, doxycycline induction of protein expression for 8 h results in a 
lower increase in expression of the p24 fusion protein compared to the level of 
increase after 24 h induction. When p24 wt and p24L17F (lane 7 and 9) are 
analyzed after 24 hours of induction, the amount of endogenous and 
exogenous p24 protein expressions is comparable.  
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FIGURE 14: Different time points of induction for recombinant p24 expression 
in stable cell lines. HeLa-YFP-p24-wt and –p24L17F cell lines were lysed after 8 h 
and 24 h doxycycline induction and subjected to 4-12%Bis-Tris NuPAGE gel. 
Western blot analysis with an antibody against the p24 protein (Elfriede).  
 
In order to monitor the degree of oligomerization of the p24 wt and p24L17F 
fusion proteins, in vivo crosslinking reagents were applied to the stable cell 
lines. Expression of recombinant proteins was induced by 24 h doxycycline 
incubation and cells were subjected to chemical crosslinking using the 
membrane-permeable, homobifunctional amine-reactive reagent 
disuccinimidyl glutarate (DSG; 0.5 mM in DMSO) for 15 min. Cross-linked 
products of p24 wt and p24L17F proteins were then analyzed by western blot. 
As shown in the Figure 15, control HeLa MCAT cells display only endogenous 
p24 protein and not cross links in the blot, while in the lanes with HeLa cells 
expressing p24 wt and p24L17F in addition the YFP tagged proteins are seen. 
In the experimental setups incubated with DSG cross-linker, YFP tagged p24 
and p24L17F amounts are reduced and oligomerized cross-linked products are 
present with an apparent MW of 100 kDa and higher (Figure 15).  
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FIGURE 15: In vivo oligomerization of recombinant p24 proteins. After 24 h 
doxycycline induction, stable cell lines were incubated with 0.5 mM DSG cross-linker 
for 15 min. Cells were lysed and subjected to western blot analysis. Antibody against 
p24 (Elfriede) was used to label the membrane.  
 
Cross-linked p24 wt and p24L17F proteins were quantified and compared as 
ratios to monomeric recombinant proteins, respectively. p24 wt 
oligomer/monomer ratios were set to 100% and compared to p24L17F 
oligomer/monomer ratios. YFP tagged p24 wt oligomer/monomer- and 
p24L17F oligomer/monomer-ratios were analyzed by two-tailed, paired t-tests 
as depicted in Figure 16.  
 
 
FIGURE 16: In vivo oligomerization propensity of HeLa cell lines stably 
transfected with YFP-p24 wt or YFP-p24L17F. YFP-p24 wt oligomer/monomer 
ratios were set to 100% (black bar; n=4) and YFP-p24L17F oligomer/monomer ratios 
are given as percentages hereof (white bar; 61.57% ±17.7 SD; n=4). YFP-p24 wt 
oligomer/monomer- and YFP-p24L17F oligomer/monomer-ratios were analyzed by 
two-tailed, paired t-tests (p=0.0165 (*)). 
62 
 
 
Binding of SM 18 was likely to be blocked via the single mutation at the 
transmembrane domain of the p24 protein (Contreras et al, 2012). As a result 
of in vivo chemically crosslinking of p24 wt and p24L17F, there is a significant 
shift in the equilibrium between oligomeric forms to the monomeric form of the 
non-SM 18 binding p24 protein.  
 
3.4. CHAPTER IV: Kinetics of the p24 family members 
 
3.4.1. Expression levels of the recombinant proteins 
 
In order to address the kinetics of the p24 family members, one representative 
candidate from each group by virtue of their different travel rates; p23 and p24 
was chosen according to the results of previous Wieland Laboratory member 
(Eva Emig, PhD thesis). Chinese hamster ovary (CHO) cell lines which express 
fluorescent-tagged p23 and p24 in a doxycycline-dependent manner were 
used. These cell lines were also used for the initial experiments. Cells were 
plated with 40% confluency. Plated cells were induced with doxycycline for 8 h 
and 24 h to confirm expression and compare the expression levels of the 
recombinant proteins. After the incubation, cells were lysed and subjected to 
western blot analysis using antibodies against p23 and p24 proteins. As shown 
in Figure 21, stably transfected CHO cell lines express endogenous p23 and 
p24 proteins, but expression levels of exogenous protein in increasing time 
points are not comparable between the two stable cell lines. The expression 
level of the recombinant protein from the CHO-YFP-p23 cell line is low 
compared to the expression of CHO-YFP-p24 cell line.  
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FIGURE 21: Expression levels of the stable cell lines after various induction 
times. CHO-YFP-p23 and CHO-YFP-p24 cell lines were incubated with doxycycline 
for 8 h and 24 h and lysed. 10% of the total cell lysates were subjected to 4-12% 
Bis-Tris NuPAGE gels. Western blot analysis was performed using anti-p24 
(Elfriede) and -p23 (Henriette) antibodies.  
 
In parallel, the same number of cells were plated and visualized through 
fluorescent microscopy. The expression level of recombinant p23 protein 
resulting from an 8 h induction was too low to be detected, thus cells were 
induced with doxycycline for 24 h. Surprisingly, the average expression level of 
p23 was not low; instead, the number of cells expressing recombinant protein 
was low (Figure 22).  
 
FIGURE 22: Expression of the recombinant p24 family members after 24 h 
doxycycline induction. CHO-YFP-p23 and CHO-YFP-p24 cell lines were induced 
for recombinant protein expression with doxycycline for 24 h and then visualized by 
microscope.  
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3.4.2. Localization of the recombinant proteins in the cell 
 
Characterization of the CHO cell lines with immunofluorescence techniques 
was necessary to confirm the correct localization of the exogenously expressed 
tagged p24 family members compared to their endogenous counterparts. 
Taking into account the recombinant protein expressing cell number of the 
CHO-YFP-p23 cell line was not detectable after 8 h of induction, cells after 24 
h induction were immune stained and the colocalization of the recombinant 
proteins was compared with the cis-Golgi marker GM130, the Endoplasmic 
Reticulum-Golgi Intermediate Compartment marker ERGIC53, and 
Endoplasmic Reticulum marker Calnexin.  
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FIGURE 23: Colocalization of recombinant p23 protein in stable CHO cell lines. 
CHO-YFP-p23 cell lines were immune labeled for colocalization of the recombinant 
protein with various antibodies that immune label organelles in the early secretory 
pathway. Colocalization of YFP tagged p23 (yellow) with GM130, ERGIC53 and 
Calnexin (red) can be seen in the merge image (green).    
 
 Immune labelling of CHO-YFP-p23 expressing cell lines (Figure 23) implies a 
colocalization with Golgi, ERGIC and ER markers. Additionally, the number of 
cells expressing YFP-p23 is low when compared with the cells labeled with 
other markers (Figure 23, merge). The recombinant protein signal from CHO-
YFP-p24 cell lines colocalizes with the ER, ERGIC and Golgi markers in the 
merged images (Figure 24). Furthermore, stable CHO cell lines were immune 
labelled with p23 and p24 antibodies to compare the localization of the 
exogenous protein versus endogenous protein. As a result, both recombinant 
proteins colocalize with the endogenous protein nicely (data not shown). 
Together these results are consistent with the fact that p23 and p24 proteins 
constantly cycle in the early secretory pathway (Gommel et al. 1999). In 
addition, the results determine the correct time interval for the induction of the 
exogenous protein expression since there was no accumulation of the 
exogenous protein in any compartment of the cell.  
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FIGURE 24: Colocalization of recombinant p24 protein in stable CHO cell line. 
CHO-YFP-p24 cells were subjected to immunofluorescence labeling with Golgi, 
ERGIC and ER markers for visualizing the colocalization. Colocalization of YFP 
tagged p24 (yellow) with GM130, ERGIC53 and Calnexin (red) is seen in the merged 
images (green).  
 
3.4.3. Fluorescence Loss in Photobleaching of p24 family members 
 
With FLIP the fluorescence intensity of a region of interests (ROI) is monitored 
while another ROI is bleached constantly. This allows to investigating if the two 
regions are connected and fluorescent proteins can move between them. This 
technique was used to monitor the fluorescence loss in the Golgi while 
bleaching parts of the ER to investigate the retrograde transport of the p24 
family members (Phair and Misteli, 2001).  
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Stable CHO cell lines were tested for their suitability in Fluorescence Loss in 
Photobleaching (FLIP) experiments. One of the limiting factors is the 
heterogeneity of the recombinant protein expression in the two different cell 
lines. Therefore, the CHO-YFP-p23 cell line was subjected to Fluorescence-
activated cell sorting (FACS) to collect a population of cells similar in expression 
to the CHO-YFP-p24 cell line. After the successful sorting, cells were subjected 
to FLIP experiments. However, despite several trials, CHO cell morphology was 
not suitable for the FLIP experiments, and the stable CHO cell lines could not 
be used for this experiment.  
 
Instead of using CHO cells, p23 and p24 proteins were tagged with YFP and 
transiently expressed in HeLa cells. This system proved to be suitable for FLIP 
experiments.  
 
The established method for Fluorescence Loss in Photobleaching (FLIP) was 
employed as conducted by Contreras et al. (2012) for the analysis of p24 
proteins. Here, two Regions of Interest (ROI) of defined size were selected in 
each cell, parallel to each other, on both sides of the Golgi area. The distance 
between the ROIs and Golgi area as well as the sizes of the ROIs were 
determined in control experiments: The ROI’s were placed at a certain distance 
to both sides of the Golgi area and moved closer each time to find regions that 
avoided bleaching of the Golgi ROI by the illumination beam. As an additional 
control, cells were fixed and subjected to the FLIP experiment. Once the area 
sizes and the positions were defined, live experiments were performed 
accordingly.  
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FIGURE 25: Sequence images from two FLIP experiments of HeLa cell lines 
transfected with YFP-p24. ROI #1 is within the Golgi area, ROI #2 is the background 
control, and ROI #3 and #4 are bleaching areas. Arrows points to the appearance of 
the YFP tagged proteins in different parts of the cell. 
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Figure 26: Sequence images from two FLIP experiments of HeLa cell lines 
transfected with YFP-p23. ROI #1 is within the Golgi area, ROI #2 is the background 
control, and ROI #3 and #4 are bleaching areas. Arrows points to the appearance of 
the YFP tagged proteins in different parts of the cell. 
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Figure 25 and 26 shows representative sequence images from examples of 
FLIP experiment where HeLa cell lines are transiently transfected with YFP-
p24 and YFP-p23. ROI #3 and #4 are the bleaching ROI’s and were placed in 
parallel. ROI #2 was used as a background control. ROI #1 was placed at the 
Golgi area. While ROI #3 and #4 were bleaching, the fluorescence intensity 
decreases in ROI #1 was monitored. As the YFP tagged p23 and p24 proteins 
cycle from Golgi ROI to bleaching ROI’s and back, the fluorescent proteins were 
bleached and the total fluorescence intensity of the Golgi ROI decreased. 
Arrows in Figure 25 and 26 indicate additional protein transport activity as the 
fluorescent-tagged proteins appear and disappear in other regions of the cell 
during the sequence of images.  
 
Half-life p23/p24: 1.10 ± 0.95 min 
 
FIGURE 27: Quantification of the FLIP experiments. Average half lifes of the 
YFP-p23 and YFP-p24 fluorescence intensity are compared. P-value of two tailed, 
unpaired t test (>0.05) is presented. The number of individual experiments 
performed for YFP-p23 (n= 27) and for YFP-p24 (n=34) is given. 
 
 
Quantification of the FLIP data is shown in Figure 27. Half-lifes of the two 
proteins fluorescent decays were calculated and compared. The difference of 
the half-lifes of YFP-p23 to YFP-p24 was not significant according to the two 
tailed unpaired t test.  
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3.4.4. Photoswitchable protein tag: Dronpa 
 
In order to selectively follow up protein trajectories, another fluorescent tag was 
fused to p23 and p24 proteins as a reporter protein: the photo-switchable 
fluorescent tag, dronpa (Day and Davidson, 2009). There are several 
advantages of this novel GFP-like protein. The dronpa has a photo-activatable 
feature; it can be activated or deactivated with different wavelengths, 
repeatedly. Once it is activated at the region of interest, it is possible to follow 
the path of the tagged proteins as they are transported throughout the cell. 
Therefore, this technique is more sensitive and provides an additional method 
of obtaining protein transport rates.  
 
After the constructs were created, the transient transfection of HeLa cells was 
optimized. Cells were transfected simultaneously for western blot analysis and 
visualization under the microscope.    
  
FIGURE 28: Transient transfection of HeLa cell lines with dronpa constructs. 
HeLa cells were transfected with dronpa constructs and subjected to western blot. 
5% and 10% of the cell lysates were loaded on SDS-PAGE gel and labeled with 
antibodies against p24 (Elfriede), p23 (Henriette), and dronpa (GFP). 
 
Transfected HeLa cells were lysed and increasing amounts of the cell lysates 
were subjected to western blot analysis with antibodies against p23, p24 
proteins and dronpa (Figure 28). Transiently transfected cells with pDronpa-
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p24 show both endogenous and exogenous proteins at the expected size. 
Nevertheless, pDronpa-p23 transfected cells show only the endogenous 
proteins at the expected size (20 kDa). The exogenous protein is not present 
in the blot. Besides, there is a strong band at the size of truncated dronpa. As 
DNA sequencing showed not stop codon between the dronpa tag and the p23 
protein, it seems that pDronpa-p23 is degraded after transfection.  
 
In order to directly visualize the constructs in vivo, transfected cells were 
observed by confocal microscopy. pDronpa-p23 transfected cells showed  
fluorescence predominantly in the cytosol as shown in Figure 29. pDronpa-p24 
transfected cells, on the other hand, show perinuclear localization (Figure 29).  
 
Together these findings show that the pDronpa-p23 has to be improved, while 
a pDronpa-24 construct was successfully created.   
 
 
FIGURE 29: Microscope image of cells transfected with dronpa constructs. 
HeLa cells were transfected with pDronpa-p23 and pDronpa-p24 for 24 h and 
observed in vivo.  
 
The functional pDronpa-p24 was investigated further. To this end, pDronpa-p24 
transfected cells were immune-labeled with a cis-Golgi marker (Figure 30). 
When we focused on the transfected cells with pDronpa-p24, the dronpa 
tagged p24 (green) colocalizes with GM130 (red). Since p24 protein is known 
to be mainly located in the Golgi area, this colocalization shows the correct 
localization of the recombinant protein.  
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FIGURE 30: Colocalization of pDronpa-p24 with a cis-Golgi marker. HeLa cells 
transfected with pDronpa-p24 is labeled with a cis-Golgi marker. pDronpa-p24 
(green), GM130 (red),  colocalization (yellow).  
 
Taken together, pDronpa-p24 construct was cloned and verified to localize 
properly at the perinuclear region.
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4. Discussion  
 
4.1. CHAPTER I: Role of γ2-COP in the transport of SH4 domain 
containing proteins 
 
Here we investigated a potential specific role of either of the two γ subunits of 
coatomer in the unconventional transport of two reporter proteins by different 
cell lines. To study the role of γ2-COP in the transport of the SH4 domain 
containing HASPB and Yes proteins, stable cell lines were created and tested 
in biochemical and microscopy analysis. 
 
Clathrin coated vesicles are responsible for trafficking in the late secretory 
pathway (trans-Golgi network, endosomes, lysosomes, plasma membrane) in 
eukaryotic cells are, and are often compared to the COPI system because of 
their structural analogy that has emerged due to a growing set of X-ray 
crystallographic structures of bits and pieces of such complexes (Popoff et al., 
2011a; Robinson, 2004). Their coats consist of an outer layer (Clathrin heavy 
and light chains) and an inner layer (adaptor proteins). Similarly, the heptameric 
coatomer complex can be dissociated into tetrameric (β/δ/γ/ζ-COP) and trimeric 
(α/β’/ε-COP) subcomplexes. The tetrameric coatomer subcomplex shares 
similarities to the adaptor proteins of the clathrin coat, while the trimeric 
coatomer subcomplex is similar to the heavy and light chains of clathrin (Popoff 
et al., 2011a; Xing et al., 2010).  
 
Furthermore, there are different adaptor complexes of the clathrin coat. These 
are located in different parts of the late secretory pathway and fulfill different 
functions (Robinson, 2004). In a similar way there are four different isoforms of 
coatomer, which are expressed in different amounts and located to different 
parts of the Golgi apparatus (Moelleken et al., 2007). It is highly likely for the 
different COPI isoforms to also exhibit different functions, similar to the many 
clathrin adaptor complexes known. Recently, a selectivity for cargo of the COPI 
isoforms has been investigated: Electron microscopy and biochemical studies 
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revealed compositionally distinct populations of COPI vesicles in in vivo and in 
vitro systems (Malsam et al., 2005; Orci et al., 1997).  
 
Preliminary data from Nickel Laboratory showed that transport of HASPB (SH4-
protein) is affected by down regulation of γ2-COP. Ritzerfeld et al. described 
that down regulation of β-COP in HeLa cell lines expressing both SH4-proteins 
results in retention of the HASPB in the perinuclear region while Yes was able 
to reach to plasma membrane. As stable cell lines expressing the SH4-proteins 
HASPB and Yes were available (Ritzerfeld et al., 2011), we extended our 
knockdown experiments to other coatomer subunits α, β, δ, ζ and especially to 
γ-COP to validate the preliminary data and to obtain more insights on the role 
of different subunits in the trafficking of SH4-proteins. siRNA knockdown 
experiments in mammalian cells show a reduction of the respective coatomer 
subunits (α, β, δ, ζ1-COP), which leads to a significant phenotype for one of the 
SH4-proteins: HASPB. However, knockdown of individual γ subunits did not 
affect transport of HASPB protein. Therefore, our data shows that transport of 
SH4-proteins to the plasma membrane is dependent on the coatomer complex, 
and therefore most likely on COPI vesicles. However, in the scope of this thesis, 
it could be shown that when one of the γ subunits was down regulated, the 
other subunits were sufficient to rescue the transport of the SH4-protein HASPB 
to the plasma membrane.  
 
Furthermore, previously created stable cell lines expressing HA and myc 
tagged γ1-COP and γ2-COP (respectively) from Jörg Moelleken were used as 
a template. When the mouse fibroblast cell line 3T3 was characterized, 
unexpectedly, a down-regulation of the endogenous proteins was observed, 
while the exogenous γ-COP subunits were increased. This resulted in only one 
of the tagged γ-COP subunits being present in 3T3 cells after induction. Newly 
created cell lines are stably expressing the reporter proteins, which already 
carry a γ subunit knockdown system as the template 3T3 cells. The 
recombinant proteins were expressed in the new 3T3 cell lines and analyzed. 
However, again there was no different phenotype between γ subunits.  This 
indicates that upon down regulation of one of the γ subunits, the other one was 
able to rescue transport of SH4-proteins to the plasma membrane. A possible 
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explanation for this might be that in case of a lack in the coatomer isoforms in 
cells, other isoforms can take initiative in the transport of this cargo to fulfill the 
task. However, this could also be interpreted by coatomer isoforms having no 
preference for transporting different SH4-proteins to the plasma membrane.  
 
Knock down of the coatomer subunits also showed the absence of the ζ2 
subunit in HeLa cells. Recently, analyses of ζ subunits existing in cancer cells 
versus normal cells opened up a new path for cancer therapeutics (Shtutman 
et al., 2011). Shtutman and colleagues showed different levels of the two ζ 
subunits in different cancer cell lines by qRT-PCR and revealed a possibility of 
targeting ζ1-COP for the treatment of the cancer cells. Our findings show a 
pronounced retention effect of ζ1 subunit knockdown in the transport of HASPB 
reporter protein. These results are consistent with the previous studies and 
suggest in a cell with only one copy of ζ subunit makes ζ1-COP indispensable. 
Taken together, the functions of the coatomer isoforms can be substituted by 
other isoforms in our cell culture system but this does not exclude that there are 
special circumstances where the presence of one subunit is vital for the 
organism. These might be special cell types, special cargo or special 
environmental conditions.  
 
It appears that there is no significant role of γ2-COP in the plasma membrane 
localization of the SH4-proteins. However, in the scope of this thesis, only two 
SH4-proteins could be investigated. Clearly, this investigation should be 
extended to a variety of SH4-proteins and other proteins that carry different 
domains, ideally to a genome wide scale. The cell biological analysis could be 
combined with biochemical analyses and include cargo proteins with known 
preferences for one or the other γ subunit in future experiments. For example, 
in vitro experiments resulted in uptake differences of some cargo 
(MannosidaseII and GOLPH3) within the COPI vesicles generated from 
different coatomer isoforms (personal communication, Vincent Poppof, Britta 
Brügger, Felix Wieland).  
 
It is also tempting to extend the analysis to a multitude of proteins of a given 
cell. This could be done for example by monitoring the levels of all cell surface 
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proteins in γ1 and γ2 knock downs compared to the wild type, by proteomic 
analysis of the pull-down of surface labeled (NHS-sulfo-Biotin) proteins or 
quantitative FRET analysis.  
 
4.2. CHAPTER II: Impact of Brefeldin A analogues on Golgi 
morphology 
 
Brefeldin A (BFA) is a unique fungal metabolite that has the unusual property 
of (reversibly) disassembling the structure of the Golgi apparatus (Lippincott-
Schwartz et al., 1989). This causes a block of protein transport between the ER 
and the Golgi in eukaryotic cells (Fujiwara et al., 1988). In addition, BFA has an 
inhibitory effect on enterovirus replication (Cuconati et al., 1998) and an 
apoptotic effect on cancer cells (Seehafer et al., 2013; Shao et al., 1996).  
 
In this chapter, effects of novel BFA analogues on mammalian cells were 
investigated. In comparison to the effect of BFA, two sets of newly synthesized 
analogues were tested at concentrations of 1 µg/ml and 5 µM and different 
times (30 min, 60 min, and 2 h wash-out after 60 min).  
 
In a first batch 6 analogues were tested. Two of the six analogues were 
affecting the Golgi morphology, namely, (6R)-hydroxy-BFA and BFA lactam 
analogue. The BFA lactam analogue differed from the other compounds in an 
earlier start of Golgi reassembly, 60 min even before washout. This reassembly 
effect before washout is likely due to a metabolisation or secretion of the drugs 
(Bruning et al., 1992; Förster et al., 2011a). Treatment with all compounds of 
the second set showed an effect on the Golgi morphology similar to BFA. Once 
compounds were washed out, only the Golgi dissociation caused by derivative 
39e turned out to be reversible, again similar to BFA. The other two compounds 
(39a and 39b) after wash out only partially allowed to regain the structure of the 
Golgi, while one of the compounds (5) did not at all allow recovery of the Golgi. 
 
Although BFA itself is an important tool used in vesicular transport studies 
(Helms and Rothman, 1992b); it is also of interest for other fields of research, 
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e.g. it is a potential anti-cancer and anti-viral drug. The cytotoxic effect of BFA 
is known in various human cancer cells (Tseng et al., 2013). Tseng and 
colleagues performed cell culture experiments by determining the survival rate 
of the suspension and adhesion cultures under increasing amount of BFA 
treatment conditions and observed BFA-mediated suppression of the progress 
of colorectal cancer (one of the most common cancer types) during the stages 
of tumorogenesis and metastasis. Furthermore, the impact of BFA on 
androgen-mediated prostate cancer cell growth was investigated by focusing 
on the cell cycle and androgen receptor regulation by Rajamahanty and 
colleagues. They found BFA to exert a very strong growth inhibitory activity on 
androgen-mediated prostate cancer cell lines by cell cycle arrest and the down 
regulation of androgen receptor activity and expression (Rajamahanty et al., 
2010). Another important effect of BFA is on the function in the entry of virus, 
their replication and assembly (van der Linden et al., 2010). For example, 
Dasgupta and Wilson showed that a primary effect of BFA on Herpes Simplex 
Virus type1 is an assembly defect, during formation of perinuclear enveloped 
virus particles at the inner nuclear membrane (Dasgupta and Wilson, 2001).  
 
In the scope of this thesis, BFA analogues with different effects on Golgi 
disruption and reassembly in mammalian cells were analyzed that have great 
potential to be used in other fields. Unlike BFA, more stable, less toxic, not 
reversible etc. analogues could be useful as therapeutics. Based on these 
findings, it might be possible to develop new therapies for treatment of various 
cancers.  
 
4.3. CHAPTER III: Oligomerization of p24 and p24L17F 
transmembrane domains 
 
All members of the p24 family cycle within the early secretory pathway 
(Gommel et al., 2001; Jenne et al., 2002; Schuiki, 2012) as they are recognized 
via their cytoplasmic tails and transported by COPI and COPII vesicles 
(Dominguez et al., 1998; Schuiki, 2012; Sohn et al., 1996). In addition to their 
monomeric and dimeric forms, most p24 family members form heterooligomers 
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within the family, which is essential for their proper localization and stability 
(Jenne et al., 2002; Gommel et al., 1999). Recently, higher oligomeric forms of 
p24 were observed upon in vivo crosslinking (Contreras et al., 2012; this 
thesis). This is especially interesting as the biogenesis of COPI vesicle is 
initiated by the binding of the cytoplasmic tails of dimeric p24 proteins to Arf 
and then to the γ-COP (Gommel et al., 2001; Bethune et al., 2006; Zhao et al., 
1999).  
 
In addition to the oligomeric forms and the protein-protein interactions of the 
p24 family members, recent experiments revealed an interaction between p24 
with a specific lipid. This interaction was not observed with the very closely 
related p23 protein (Contreras et al., 2012). The interaction of the 
transmembrane domain of p24 with a specific sphingolipid species (SM 18:0) 
was revealed by FRET experiments with fluorescent lipids. The oligomeric form 
of p24 and a non-SM18 binding p24 variant (L17F) were investigated in vivo as 
part of the thesis.  
 
Optimization of the doxycycline induction resulted in the comparable amount of 
expression levels of the recombinant proteins. The recombinant p24 proteins 
were successfully cross-linked in vivo using a chemical crosslink agent. 
Quantification of in vivo crosslink experiments implies a significant reduction in 
the oligomeric forms to monomeric forms ratio of p24L17F. These data are a 
strong indication that the shift in equilibrium of p24 as found in vitro does also 
occur in vivo, and that SM 18 binding is of physiological importance. In 
accordance with the in vitro crosslinking data on transmembrane domains of 
p24, the specific interaction of sphingolipid (SM 18:0) with the transmembrane 
domain of p24 facilitates oligomerization of the p24 in vivo as well. This work 
was published in Contreras et al. (2012).  
 
4.4. CHAPTER IV: Kinetics of the p24 family members 
 
Members of the p24 family cycle between the membrane bound compartments 
of the early secretory pathway. Indications existed from earlier experiments, 
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that individual members of the family cycle at different rates. In vivo trafficking 
of fluorescently tagged p23 and p24 from the ERGIC to the Golgi could be 
examined by microscopy after temperature shifts and was estimated to move 
at 9.7 µm in 10 seconds in the average, with varying speeds (max. speed 1.6 
µm/s) (Blum et al., 1999). In yeast, deletion of the p24 family members resulted 
in a reduction of the speed of ER to Golgi transport for a subset of secretory 
proteins (Denzel et al., 2000; Marzioch et al., 1999). In addition, immune 
fluorescent labeling revealed two distinct groups of p24 family members, 
distinguished by different travel rates from the Golgi to the ER (Eva Emig, PhD 
thesis).  
 
In this thesis, in the anticipation to challenge the kinetics of the p24 family 
members, two proteins were investigated (p23 and p24). Detailed 
characterization of the cells expressing fluorescent-tagged (YFP) p23 and p24 
proteins at hand was carried out.  
 
Biochemical and microscopic analysis revealed heterogenic expression levels 
of the recombinant proteins, which were solved by Fluorescence Activated Cell 
Sorting (FACS) of the cells. 
 
Golgi export kinetics of the p24 proteins were examined in comparison to the 
non-SM 18 binding p24 mutant (p24L17F) by FLIP. This showed a reduction in 
the half-life of Golgi-associated fluorescence of fluorescence-tagged p24 to 4.5 
min (Contreras et al., 2012). Despite the fact that the cell morphologies were 
quite different, several trials of FLIP experiments were performed with the 
previously defined settings for HeLa cell lines. CHO cell lines are 
morphologically more elongated compared to HeLa cell lines. Setting up ROI’s 
on the both sides of the Golgi area with a certain distance to protect the cell 
from unintended bleaching was not possible but for a few cells in hundreds. 
This obstacle could be overcome by adjusting the settings for these cell lines: 
the ROI size, number and/or location.  
 
In the end, FLIP experiments were performed successfully with HeLa cell lines. 
Nevertheless, no significant differences were observed between transport rates 
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of p23 and p24 from Golgi to ER with these means, although in individual 
experiments such differences could be observed.  
 
Another fluorescent protein tag with more advantages additional to those 
offered by YFP was introduced to p23 and p24 proteins as a fusion protein. It 
is a novel GFP-like protein with a photo-activatable feature, which was 
previously used for tracking of proteins in vivo (Andresen et al., 2007; Fujioka 
et al., 2006). Photoactivatable fluorescent proteins (PFAPs) are recently 
discovered, useful reporters of the dynamic behavior of proteins in vivo and a 
great tool for the microscopy of the kinetics of proteins in living cells (Day and 
Davidson, 2009; Lukyanov et al., 2005). Dronpa is the most prominent and well-
studied member of the photoactivatable fluorescent proteins (Day and 
Davidson, 2009). To investigate the kinetics of p24 family members, p23 and 
p24 Dronpa fusion constructs were created. One of the dronpa constructs 
(pDronpa-p24) was produced successfully and analyzed biochemically and 
microscopically. However, pDronpa-p23 constructs did not yield stable 
recombinant protein according to in vivo and biochemical analysis. The 
predominantly cytosolic localization of the pDronpa-p23 construct in vivo is 
likely due to proteolytic truncation of the more stable Dronpa protein domain.  
 
The Dronpa-tagged p24 protein family members can be activated at the 
location of interest and follow up their path throughout the cell, thereby 
obtaining protein transport rates. The cloning strategy for pDronpa-p23 will 
have to be altered and improved to achieve a more stable construct. If a stable 
clone of pDronpa-p23 was available, future experiments could provide further 
insights into the transport rates of p24 family members. Eventually, such 
experiments should be extended to other members of the p24 family.  
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5. Appendix 
 
5.1. Abbreviations 
 
3T3g1 3T3/rtTA-HA-hγ1  
3T3g2 3T3/rtTA-Myc-hγ2  
ADP Adenosine diphosphate 
Arf1 ADP-ribosylation factor 1 
BFA Brefeldin A 
BSA Bovine serum albumin 
C Centigrade 
C-terminal carboxy-terminal  
CHO Chinese hamster ovary  
COP Coat Protein 
DMEM Dulbecco’s Modiﬁed Eagle's Medium 
DMSO Dimethyl sulfoxide  
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphates  
DSG Disuccinimidyl glutarate  
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
ER Endoplasmic Reticulum 
ERGIC Endoplasmic Reticulum-Golgi Intermediate Compartment  
FACS Fluorescence-activated cell sorting  
FBS Fetal Bovine Serum 
FCS Fetal Calf Serum 
FGF Fibroblast growth factor 
FLIP Fluorescence Loss in Photobleaching  
FSC Forward scatter 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GBF1 Golgi-specific Brefeldin A resistant guanine nucleotide exchange factor 1 
GDP Guanosin diphosphate 
GEF Guanine Exchange Factor  
GFP Green Fluorescent Protein 
GPI Glycosylphosphatidylinositol 
GTP Guanosin triphosphate 
h Hour(s) 
HASPB Hydrophilic Acylated Surface Protein B 
HEK Human Embryonic Kidney 
HeLa 
double5  HeLa SH4‐HASPBN18‐GFP/SH4‐YesN18‐Cherry Clone#5  
IgG immunoglobulin G 
IP immunoprecipitation 
kb kilo base pairs 
kDa kilo-Dalton 
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LB Luria Broth 
LSM Laser Scanning Microscopy 
min Minute(s) 
MW Molecular Weight  
N-terminal Amino terminal  
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PVDF Polyvinylidene difluoride 
qRT-PCR Quantitative real time PCR  
ROI Region(s) of Interest  
rpm Revolutions per minute 
SDS Sodium dodecyl sulfate 
sec Second(s) 
siRNA Small interfering RNA 
TEMED N, N, N’, N’-Tetramethylethylenediamine 
V Volt 
wt wild type 
YFP Yellow Fluorescent Protein 
α Alpha 
β Beta 
β’ Beta prime 
γ Gamma 
δ Delta 
ε Epsilon 
ζ Zeta 
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van Kuppeveld, and Christian D. Klein. J. Med. Chem., 2013, 56 (14), 5872–
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Molecular recognition of a single sphingolipid species by a protein’s 
transmembrane domain. F.-Xabier Contreras, Andreas M. Ernst, Per 
Haberkant, Patrik Björkholm, Erik Lindahl, Başak Gönen, Christian Tischer, 
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